Form 8-K

8-K — AFLAC INC

Accession: 0001628280-26-054333

Filed: 2026-08-06

Period: 2026-08-06

CIK: 0000004977

SIC: 6321 (ACCIDENT & HEALTH INSURANCE)

Item: Results of Operations and Financial Condition

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — afl-20260806.htm (Primary)

EX-99.1 (aflex991-q22026new.htm)

EX-99.2 (afl063026-financialsupplem.htm)

EX-99.3 (aflex993teleconferencespee.htm)

EX-99.4 (maxteleconferencepresent.htm)

GRAPHIC (afl-20260806_g1.jpg)

GRAPHIC (aflac-incorporatedx4xpro.jpg)

GRAPHIC (aflacincorporated_logo4ca.jpg)

GRAPHIC (aflaclogoa01a01a01a33.jpg)

GRAPHIC (maxteleconferencepresent001.jpg)

GRAPHIC (maxteleconferencepresent002.jpg)

GRAPHIC (maxteleconferencepresent003.jpg)

GRAPHIC (maxteleconferencepresent004.jpg)

GRAPHIC (maxteleconferencepresent005.jpg)

GRAPHIC (maxteleconferencepresent006.jpg)

GRAPHIC (maxteleconferencepresent007.jpg)

GRAPHIC (maxteleconferencepresent008.jpg)

GRAPHIC (maxteleconferencepresent009.jpg)

GRAPHIC (maxteleconferencepresent010.jpg)

GRAPHIC (maxteleconferencepresent011.jpg)

GRAPHIC (maxteleconferencepresent012.jpg)

GRAPHIC (maxteleconferencepresent013.jpg)

GRAPHIC (maxteleconferencepresent014.jpg)

GRAPHIC (maxteleconferencepresent015.jpg)

GRAPHIC (maxteleconferencepresent016.jpg)

GRAPHIC (maxteleconferencepresent017.jpg)

GRAPHIC (maxteleconferencepresent018.jpg)

GRAPHIC (maxteleconferencepresent019.jpg)

GRAPHIC (maxteleconferencepresent020.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: afl-20260806.htm · Sequence: 1

afl-20260806

0000004977false00000049772026-08-062026-08-060000004977exch:XNYS2026-08-062026-08-06

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) August 6, 2026

Aflac Incorporated

_________________________________________________________________________________________________________________________________________________________

(Exact name of registrant as specified in its charter)

Georgia 001-07434 58-1167100

(State or other jurisdiction (Commission (IRS Employer

of incorporation) File Number) Identification No.)

1932 Wynnton Road Columbus Georgia 31999

(Address of principal executive offices) (Zip Code)

706.323.3431

_________________________________________________________________________________________________________________________________________________________

(Registrant’s telephone number, including area code)

_________________________________________________________________________________________________________________________________________________________

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered

Common Stock, $.10 Par Value AFL New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 2.02 Results of Operations and Financial Condition.

On August 6, 2026, Aflac Incorporated (the "Company") issued a press release dated August 6, 2026 in which it reported the Company's 2026 second quarter financial results. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein in its entirety. In addition, a copy of the Company's second quarter supplemental earnings materials is furnished as Exhibit 99.2 to this Current Report on Form 8-K and incorporated by reference herein in its entirety.

Item 7.01 Regulation FD Disclosure.

On August 6, 2026, the Company posted to its investor relations website at investors.aflac.com a video presentation by Max Brodén, the Company's Senior Executive Vice President and Chief Financial Officer, discussing the Company's 2026 second quarter financial results. A copy of the transcript of Mr. Brodén's comments from the Investor Update and a copy of the Investor Presentation are furnished as Exhibit 99.3 and Exhibit 99.4 to this Current Report on Form 8-K, respectively, and are incorporated by reference herein in their entirety. The Investor Update and the Investor Presentation should be read in conjunction with the press release.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number Exhibit Title or Description

99.1

Press release of Aflac Incorporated dated August 6, 2026

99.2

Financial Supplement for Second Quarter 2026

99.3

Transcript of comments in video presentation by Max Brodén, Senior Executive Vice President and Chief Financial Officer of Aflac Incorporated.

99.4

Slides referenced in video presentation by Max Brodén, Senior Executive Vice President and Chief Financial Officer of Aflac Incorporated.

104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Aflac Incorporated

August 6, 2026 /s/ Robin L. Blackmon

(Robin L. Blackmon)

Senior Vice President, Financial Services

Chief Accounting Officer

EX-99.1

Filename: aflex991-q22026new.htm · Sequence: 2

Document

Aflac Incorporated Announces Second Quarter 2026 Results,

Declares Third Quarter Dividend

COLUMBUS, Ga. - August 6, 2026 - Aflac Incorporated (NYSE: AFL) today reported its second quarter results.

For the Quarter

•Total revenues were $4.1 billion, which was a 1.0% decrease year over year.

•Net earnings were $825 million, or $1.63 per diluted share, compared with $599 million, or $1.11 per diluted share a year ago.

•Adjusted earnings* were $883 million, compared with $957 million a year ago, reflecting a decrease of 7.7%.

•Adjusted earnings per diluted share* decreased 1.7% to $1.75.

•The annualized return on average shareholders’ equity was 10.9%.

•The annualized adjusted return on equity excluding foreign currency remeasurement* was 16.6%.

•The company returned $1.3 billion to shareholders, consisting of $983 million in share repurchase and $309 million in dividends.

Commenting on the company’s results, Aflac Incorporated Chairman and Chief Executive Officer Daniel P. Amos stated: "Aflac delivered solid earnings for the quarter and for the first six months. These results reflect execution of our strategy, driving long-term value for shareholders. In Japan, we have secured new opportunities through successful product initiatives including Anshin Palette (medical insurance), Miraito (cancer insurance) and Tsumitasu (life insurance). In the U.S., our focus is on meeting the evolving needs of employers and their employees with supplemental health products and related benefits.

"We continue to pursue more profitable growth and the tactical, opportunistic deployment of capital. We treasure our 2025 milestone of 43 consecutive years of dividend increases, and the Board set us on a path to extend this record in 2026. We intend to continue our balanced approach of investing in growth and driving long-term value."

AFLAC INCORPORATED CONSOLIDATED RESULTS

AFLAC INCORPORATED SELECTED OPERATING RESULTS FOR THE QUARTER

(IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS)

2Q26 2Q25 % Change

Total revenues $ 4,117 $ 4,160 (1.0) %

Net earnings 825 599 37.7 %

Adjusted earnings*

883 957 (7.7) %

Net earnings per share (diluted) 1.63 1.11 46.8 %

Adjusted earnings per share (diluted)*

1.75 1.78 (1.7) %

Total shareholders' equity 30,312 27,200 11.4 %

Total liabilities and shareholders' equity 115,961 124,736 (7.0) %

Total revenues were $4.1 billion in the second quarter of 2026, compared with $4.2 billion in the second quarter of 2025. Net earnings were $825 million, or $1.63 per diluted share, compared with $599 million, or $1.11 per diluted share a year ago. Net earnings in the second quarter of 2026 included net investment losses of $153 million, or $0.30 per diluted share, compared with net investment losses of $421 million, or $0.78 per diluted share a year ago. These net investment losses include net losses from sales and redemptions of $238 million; $77 million of current expected credit losses (CECL); impairments of $11 million; offset by an $87 million gain from an increase in the fair value of equity securities; and net gains of $86 million on certain derivatives and foreign currency activities.

Adjusted earnings* in the second quarter were $883 million, compared with $957 million in the second quarter of 2025, reflecting a decrease of 7.7%. Adjusted earnings per diluted share* decreased 1.7% to $1.75 in the quarter. The average yen/dollar exchange rate in the second quarter of 2026 was 159.45, or 9.3% weaker than the average rate of 144.60 in the second quarter of 2025. The weaker yen/dollar exchange rate had a negative $0.05 impact on adjusted earnings per share.

Shareholders’ equity was $30.3 billion, or $60.35 per share, at June 30, 2026, compared with $27.2 billion, or $50.86 per share, at June 30, 2025. Shareholders’ equity at the end of the second quarter included a cumulative increase of $10.4 billion for the effect of the change in discount rate assumptions on insurance reserves, compared with a corresponding cumulative increase of $5.6 billion at June 30, 2025 and a net unrealized loss on investment securities and derivatives of $2.8 billion, compared with a net unrealized loss of $1.8 billion at June 30, 2025. Shareholders’ equity at the end of the second quarter also included an unrealized foreign currency translation loss of $5.0 billion, compared with an unrealized foreign currency translation loss of $4.3 billion at June 30, 2025.

For the first six months of 2026, total revenues were up 12.0% to $8.5 billion, compared with $7.6 billion in the first half of 2025. Net earnings were $1.8 billion, or $3.61 per diluted share, compared with $628 million, or $1.16 per diluted share, for the first six months of 2025. Adjusted earnings for the first half of 2026 were $1.8 billion, or $3.50 per diluted share, compared with $1.9 billion, or $3.43 per diluted share, in 2025. For the first six months, the average exchange rate was 158.14, or 6.2% weaker than the rate of 148.32 a year ago. Excluding the negative impact of $0.07 per share from the weaker yen/dollar exchange rate, adjusted earnings per diluted share increased 4.1% to $3.57 for the first six months of 2026.

Shareholders’ equity excluding accumulated other comprehensive income (AOCI), or adjusted book value,* was $27.6 billion, or $55.01 per share at June 30, 2026, compared with $27.7 billion, or $51.78 per share, at June 30, 2025. Adjusted book value excluding foreign currency remeasurement* was $20.7 billion, or $41.22 per share at June 30, 2026, compared with $23.0 billion, or $42.97 per share, at June 30, 2025. The annualized adjusted return on equity excluding foreign currency remeasurement* in the second quarter was 16.6%.

AFLAC JAPAN

AFLAC JAPAN SELECTED OPERATING RESULTS FOR THE QUARTER

(IN BILLIONS OF YEN AND MILLIONS OF DOLLARS)

2Q26 2Q25 % Change 2Q26 2Q25 % Change

Total net earned premiums ¥ 245 ¥ 255 (3.7) % $ 1,537 $ 1,761 (12.7) %

Yen-denominated investment income 30 36 (14.9) % 190 246 (22.8) %

U.S. dollar-denominated investment income 70 67 4.2 % 438 464 (5.6) %

Adjusted net investment income 98 101 (2.9) % 616 699 (11.9) %

Total adjusted revenues 345 357 (3.6) % 2,161 2,472 (12.6) %

Total benefits and claims, net 157 169 (7.5) % 983 1,172 (16.1) %

Total adjusted expenses 70 74 (5.6) % 437 509 (14.1) %

Pretax adjusted earnings 118 114 3.4 % 741 790 (6.2) %

Change in bps

Premium persistency (12-mo. rolling) 92.7 % 93.7 % (100)

Total benefits and claims, net / Total net earned premiums 64.0 % 66.5 % (250)

Total adjusted expenses / Total adjusted revenues 20.2 % 20.6 % (40)

Pretax adjusted earnings / Total adjusted revenues 34.3 % 32.0 % 230

In yen terms, Aflac Japan's net earned premiums were ¥245.1 billion for the quarter, or 3.7% lower than a year ago, mainly due to the impact of a new external reinsurance transaction for WAYS and Tsumitasu as well as limited pay products reaching paid-up status. Adjusted net investment income decreased 2.9% to ¥98.3 billion, primarily due to reduced call income and lower dollar-denominated floating-rate income partially offset by higher income on U.S. dollar-denominated assets due to the weakening of the yen and higher dollar-denominated fixed-rate income. Total adjusted revenues in yen declined 3.6% to ¥344.6 billion. Pretax adjusted earnings in yen for the quarter increased 3.4% on a reported basis to ¥118.2 billion, primarily driven by favorable benefits. Pretax adjusted earnings decreased 2.1% on a currency-neutral basis. The pretax adjusted profit margin for the Japan segment was 34.3%, compared with 32.0% a year ago.

For the first six months, net earned premiums in yen were ¥491.8 billion, or 3.8% lower than a year ago. Adjusted net investment income increased 0.4% to ¥191.0 billion. Total adjusted revenues in yen were down 2.6% to ¥685.4 billion. Pretax adjusted earnings were ¥237.3 billion, or 5.8% higher than a year ago. As a result, the pretax adjusted profit margin for the Japan segment was 34.6%, compared with 31.9% a year ago.

In dollar terms, net earned premiums decreased 12.7% to $1.5 billion in the second quarter. Adjusted net investment income decreased 11.9% to $616 million. Total adjusted revenues declined by 12.6% to $2.2 billion. Pretax adjusted earnings declined 6.2% to $741 million.

For the first six months, net earned premiums in dollars were $3.1 billion, or 9.6% lower than a year ago. Adjusted net investment income decreased 6.1% to $1.2 billion. Total adjusted revenues were down 8.7% to $4.3 billion. Pretax adjusted earnings were $1.5 billion, or 0.8% lower than a year ago.

For the quarter, total new annualized premium sales (sales) decreased 5.6% to ¥19.6 billion, or $123 million, reflecting a high prior-year sales baseline for Miraito cancer insurance following its launch in March 2025, partially offset by strong growth in the refreshed Tsumitasu savings-type life insurance and Anshin Palette, the new medical insurance product launched in December 2025. For the first six months, sales increased 7.0% to ¥37.3 billion, or $235 million.

AFLAC U.S.

AFLAC U.S. SELECTED OPERATING RESULTS FOR THE QUARTER

(IN MILLIONS OF DOLLARS)

2Q26 2Q25 % Change

Total net earned premiums $ 1,539 $ 1,504 2.3 %

Adjusted net investment income 208 207 0.5 %

Total adjusted revenues 1,771 1,728 2.5 %

Total benefits and claims, net 762 712 7.0 %

Total adjusted expenses 639 628 1.8 %

Pretax adjusted earnings 370 388 (4.6) %

Change in bps

Persistency rate (12-mo. rolling) 79.4 % 79.2 % 20

Total benefits and claims, net / Total net earned premiums 49.5 % 47.3 % 220

Total adjusted expenses / Total adjusted revenues 36.1 % 36.3 % (20)

Pretax adjusted earnings / Total adjusted revenues 20.9 % 22.5 % (160)

Aflac U.S. net earned premiums increased 2.3% to $1.5 billion in the second quarter compared to the prior year, reflecting improved sales and continued strong persistency. Adjusted net investment income increased 0.5% to $208 million. Total adjusted revenues were up 2.5% to $1.8 billion. Pretax adjusted earnings were $370 million, 4.6% lower than a year ago, primarily driven by higher benefits. The pretax adjusted profit margin for the U.S. segment was 20.9%, compared with 22.5% a year ago.

For the first six months, net earned premiums increased 2.9% to $3.1 billion. Adjusted net investment income remained flat at $409 million. Total adjusted revenues were up 2.9% to $3.6 billion. Pretax adjusted earnings were $733 million, 1.7% lower than a year ago. As a result, the pretax adjusted profit margin for the U.S. segment was 20.6%, compared with 21.6% a year ago.

Aflac U.S. sales increased 2.6% in the quarter to $349 million, primarily benefiting from sales of group voluntary benefits and network dental and vision products. For the first six months, total new sales increased 2.8% to $667 million.

CORPORATE AND OTHER

CORPORATE AND OTHER SELECTED OPERATING RESULTS

(IN MILLIONS OF DOLLARS)

2Q26 2Q25 % Change

Total net earned premiums $ 176 $ 206 (14.6) %

Adjusted net investment income 114 128 (10.9) %

Total adjusted revenues 291 336 (13.4) %

Total benefits and claims, net 106 126 (15.9) %

Interest expense 62 51 21.6 %

Other adjusted expenses 133 139 (4.3) %

Total benefits and adjusted expenses 301 316 (4.7) %

Pretax adjusted earnings (10) 20 (150.0) %

For the quarter, total adjusted revenues decreased 13.4% to $291 million. Pretax adjusted earnings were a loss of $10 million, compared with a $20 million gain last year, primarily driven by lower adjusted net investment income from reduced short-term income and reduced hedge benefits that were partially offset by higher fixed-rate income. Higher interest expense and runoff impacts from closed blocks of business also contributed to the net loss for the quarter.

For the first six months, total adjusted revenues decreased 11.9% to $583 million. Pretax adjusted earnings were a loss of $10 million, compared with a gain of $63 million a year ago.

SHAREHOLDER DIVIDEND

The board of directors declared the third quarter dividend of $0.61 per share, payable on September 1, 2026 to shareholders of record at the close of business on August 19, 2026.

*See Non-U.S. GAAP Financial Measures section for an explanation of foreign exchange and its impact on the financial statements and definitions of the non-U.S. GAAP financial measures used in this earnings release, as well as a reconciliation of such non-U.S. GAAP financial measures to the most comparable U.S. GAAP financial measures.

ABOUT AFLAC INCORPORATED

Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for more than seven decades to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.1 In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance in terms of policies in force.2 The company takes pride in being there for its policyholders when they need us most, as well as being included in the World’s Most Ethical Companies by Ethisphere for 20 consecutive years (2026) and Fortune’s World’s Most Admired Companies for 25 years (2026). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/espanol.

1 LIMRA 2025 U.S. Supplemental Health Insurance Total Market Report

2 As of March 31, 2025, Aflac estimates based on company data

Aflac Incorporated periodically provides information for investors on its corporate website, investors.aflac.com, including information regarding its commitment to corporate social responsibility and sustainability, press releases, financial information, SEC filings, corporate governance materials, annual meeting information, and other information that may be important to investors.

A copy of Aflac’s financial supplement for the quarter can be found at investors.aflac.com.

Aflac Incorporated will webcast its second quarter 2026 earnings conference call on Friday, August 7, 2026 at 8:00 a.m. (ET) .

Note: Tables within this document may not foot due to rounding.

AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT

(UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)

THREE MONTHS ENDED JUNE 30, 2026 2025 % Change

Total revenues $ 4,117 $ 4,160 (1.0) %

Benefits and claims, net 1,852 2,010 (7.9)

Total acquisition and operating expenses 1,270 1,328 (4.4)

Earnings before income taxes 995 822 21.0

Income taxes 170 223

Net earnings $ 825 $ 599 37.7 %

Net earnings per share – basic $ 1.64 $ 1.12 46.4 %

Net earnings per share – diluted 1.63 1.11 46.8

Shares used to compute earnings per share (000):

Basic 504,123 536,688 (6.1) %

Diluted 505,578 538,425 (6.1)

Dividends paid per share $ 0.61 $ 0.58 5.2 %

AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT

(UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)

SIX MONTHS ENDED JUNE 30, 2026 2025 % Change

Total revenues $ 8,463 $ 7,558 12.0 %

Benefits and claims, net 3,684 3,955 (6.9)

Total acquisition and operating expenses 2,559 2,636 (2.9)

Earnings before income taxes 2,220 967 129.6

Income taxes 376 339

Net earnings $ 1,844 $ 628 193.6 %

Net earnings per share – basic $ 3.63 $ 1.16 212.9 %

Net earnings per share – diluted 3.61 1.16 211.2

Shares used to compute earnings per share (000):

Basic 508,572 540,676 (5.9) %

Diluted 510,150 542,629 (6.0)

Dividends paid per share $ 1.22 $ 1.16 5.2 %

AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED BALANCE SHEET

(UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AMOUNTS)

JUNE 30, 2026 2025 % Change

Assets:

Total investments and cash $ 103,003 $ 111,769 (7.8) %

Deferred policy acquisition costs 8,948 9,296 (3.7)

Other assets 4,010 3,671 9.2

Total assets $ 115,961 $ 124,736 (7.0) %

Liabilities and shareholders’ equity:

Policy liabilities $ 64,348 $ 78,904 (18.4) %

Notes payable and lease obligations 8,729 8,933 (2.3)

Other liabilities 12,572 9,699 29.6

Shareholders’ equity 30,312 27,200 11.4

Total liabilities and shareholders’ equity $ 115,961 $ 124,736 (7.0) %

Shares outstanding at end of period (000) 502,257 534,809 (6.1) %

NON-U.S. GAAP FINANCIAL MEASURES

This document includes references to the Company’s financial performance measures which are not calculated in accordance with United States generally accepted accounting principles (U.S. GAAP) (non-U.S. GAAP). The financial measures exclude items that the Company believes may obscure the underlying fundamentals and trends in insurance operations because they tend to be driven by general economic conditions and events or related to infrequent activities not directly associated with insurance operations.

Due to the size of Aflac Japan, where the functional currency is the Japanese yen, fluctuations in the yen/dollar exchange rate can have a significant effect on reported results. In periods when the Japanese yen weakens, translating Japanese yen into U.S. dollars results in fewer U.S. dollars being reported. When the Japanese yen strengthens, translating Japanese yen into U.S. dollars results in more U.S. dollars being reported. Consequently, Japanese yen weakening has the effect of suppressing current period results in relation to the comparable prior period, while Japanese yen strengthening has the effect of magnifying current period results in relation to the comparable prior period. A significant portion of the Company’s business is conducted in Japanese yen and never converted into U.S. dollars but translated into U.S. dollars for U.S. GAAP reporting purposes, which results in foreign currency impact to earnings, cash flows and book value on a U.S. GAAP basis. Management evaluates the Company's financial performance both including and excluding the impact of foreign currency translation to monitor, respectively, cumulative currency impacts and the currency-neutral operating performance over time. The average yen/dollar exchange rate is based on the published MUFG Bank, Ltd. telegraphic transfer middle rate (TTM).

The company defines the non-U.S. GAAP financial measures included in this earnings release as follows:

•Adjusted earnings are adjusted revenues less benefits and adjusted expenses. Adjusted earnings per share (basic or diluted) are the adjusted earnings for the period divided by the weighted average outstanding shares (basic or diluted) for the period presented. The adjustments to both revenues and expenses account for certain items that are outside of management’s control because they tend to be driven by general economic conditions and events or are related to infrequent activities not directly associated with insurance operations. Adjusted revenues are U.S. GAAP total revenues excluding adjusted net investment gains and losses. Adjusted expenses are U.S. GAAP total acquisition and operating expenses including the impact of interest from derivatives associated with notes payable but excluding any non-recurring or other items not associated with the normal course of the Company’s insurance operations and that do not reflect the Company's underlying business performance. Management uses adjusted earnings and adjusted earnings per diluted share to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of these financial measures is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The most comparable U.S. GAAP financial measures for adjusted earnings and adjusted earnings per share (basic or diluted) are net earnings and net earnings per share, respectively.

•Adjusted earnings excluding current period foreign currency impact are computed using the average foreign exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign exchange rate changes. Adjusted earnings per diluted share excluding current period foreign currency impact is adjusted earnings excluding current period foreign currency impact divided by the weighted average outstanding diluted shares for the period presented. The Company considers adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact important because a significant portion of the Company's business is conducted in Japan and foreign exchange rates are outside management’s control; therefore, the Company believes it is important to understand the impact of translating foreign currency (primarily Japanese yen) into U.S. dollars. The most comparable U.S. GAAP financial measures for adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact are net earnings and net earnings per share, respectively.

•Adjusted return on equity is annualized adjusted earnings divided by average shareholders’ equity, excluding accumulated other comprehensive income. Management uses adjusted return on equity to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of this financial measure is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The Company considers adjusted return on equity important as it excludes components of accumulated other comprehensive income, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measure for adjusted return on equity is return on equity as determined using annualized net earnings and average total shareholders’ equity.

•Adjusted return on equity excluding foreign currency remeasurement is annualized adjusted earnings divided by average shareholders’ equity, excluding both accumulated other comprehensive income and the cumulative (beginning January 1, 2021) foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. The Company considers adjusted return on equity excluding foreign currency remeasurement important because it excludes both accumulated other comprehensive income and the cumulative foreign currency remeasurement gains/losses, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measure for adjusted return on equity excluding foreign currency remeasurement is return on equity as determined using annualized net earnings and average total shareholders’ equity.

•Amortized hedge costs/income represent costs/income incurred or recognized as a result of using foreign currency derivatives to hedge certain foreign currency exchange risks. These amortized hedge costs/income are estimated at the inception of the derivatives based on the specific terms of each contract and are recognized on a straight-line basis over the contractual term of the derivative. The Company believes that amortized hedge costs/income measure the periodic currency risk management costs/income related to hedging certain foreign currency exchange risks and are an important component of net investment income. There is no comparable U.S. GAAP financial measure for amortized hedge costs/income.

•Adjusted book value is the U.S. GAAP book value (representing total shareholders’ equity), less accumulated other comprehensive income as recorded on the U.S. GAAP balance sheet. Adjusted book value per common share is adjusted book value at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value and adjusted book value per common share important as they exclude accumulated other comprehensive income, which fluctuates due to market movements that are outside management’s control. The most comparable U.S. GAAP financial measures for adjusted book value and adjusted book value per common share are total book value and total book value per common share, respectively.

•Adjusted book value excluding foreign currency remeasurement is the U.S. GAAP book value (representing total shareholders’ equity), less accumulated other comprehensive income as recorded on the U.S. GAAP balance sheet and excluding the cumulative (beginning January 1, 2021) foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. Adjusted book value excluding foreign currency remeasurement per common share is adjusted book value excluding foreign currency remeasurement at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value excluding foreign currency remeasurement and adjusted book value excluding foreign currency remeasurement per common share important as they exclude both accumulated other comprehensive income and the cumulative foreign currency remeasurement gains/losses, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measures for adjusted book value excluding foreign currency remeasurement and adjusted book value excluding foreign currency remeasurement per common share are total book value and total book value per common share, respectively.

•Adjusted net investment income is net investment income adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, and ii) net interest income/expense from foreign currency and interest rate derivatives associated with certain investment strategies, which are reclassified from net investment gains and losses to net investment income. The Company considers adjusted net investment income important because it provides a more comprehensive understanding of the costs and income associated with the Company’s investments and related hedging strategies. The most comparable U.S. GAAP financial measure for adjusted net investment income is net investment income.

•Adjusted net investment gains and losses are net investment gains and losses adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, ii) net interest income/expense from foreign currency and interest rate derivatives associated with certain investment strategies, which are both reclassified to net investment income, and iii) the impact of interest from derivatives associated with notes payable, which is reclassified to interest expense as a component of total adjusted expenses. The Company considers adjusted net investment gains and losses important as it represents the remainder amount that is considered outside management’s control, while excluding the components that are within management’s control and are accordingly reclassified to net investment income and interest expense. The most comparable U.S. GAAP financial measure for adjusted net investment gains and losses is net investment gains and losses.

RECONCILIATION OF NET EARNINGS TO ADJUSTED EARNINGS

(UNAUDITED – IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS)

THREE MONTHS ENDED JUNE 30, 2026 2025 % Change

Net earnings $ 825 $ 599 37.7 %

Items impacting net earnings:

Adjusted net investment (gains) losses 106 377

Other and non-recurring (income) loss

— —

Income tax (benefit) expense on items excluded

from adjusted earnings (48) (19)

Adjusted earnings 883 957 (7.7) %

Current period foreign currency impact1

27 N/A

Adjusted earnings excluding current period foreign

currency impact2

$ 910 $ 957 (4.9) %

Net earnings per diluted share $ 1.63 $ 1.11 46.8 %

Items impacting net earnings:

Adjusted net investment (gains) losses 0.21 0.70

Other and non-recurring (income) loss

— —

Income tax (benefit) expense on items excluded

from adjusted earnings (0.09) (0.04)

Adjusted earnings per diluted share 1.75 1.78 (1.7) %

Current period foreign currency impact1

0.05 N/A

Adjusted earnings per diluted share excluding

current period foreign currency impact2

$ 1.80 $ 1.78 1.1 %

1 Prior period foreign currency impact reflected as “N/A” to isolate change for current period only.

2 Amounts excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes.

RECONCILIATION OF NET EARNINGS TO ADJUSTED EARNINGS

(UNAUDITED – IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS)

SIX MONTHS ENDED JUNE 30, 2026 2025 % Change

Net earnings $ 1,844 $ 628 193.6 %

Items impacting net earnings:

Adjusted net investment (gains) losses 3 1,301

Other and non-recurring (income) loss

— 53

Income tax (benefit) expense on items excluded

from adjusted earnings (63) (119)

Adjusted earnings 1,784 1,863 (4.2) %

Current period foreign currency impact1

35 N/A

Adjusted earnings excluding current period foreign

currency impact2

$ 1,819 $ 1,863 (2.4) %

Net earnings per diluted share $ 3.61 $ 1.16 211.2 %

Items impacting net earnings:

Adjusted net investment (gains) losses 0.01 2.40

Other and non-recurring (income) loss

— 0.10

Income tax (benefit) expense on items excluded

from adjusted earnings (0.12) (0.22)

Adjusted earnings per diluted share 3.50 3.43 2.0 %

Current period foreign currency impact1

0.07 N/A

Adjusted earnings per diluted share excluding

current period foreign currency impact2

$ 3.57 $ 3.43 4.1 %

1 Prior period foreign currency impact reflected as “N/A” to isolate change for current period only.

RECONCILIATION OF NET INVESTMENT (GAINS) LOSSES TO ADJUSTED NET INVESTMENT (GAINS) LOSSES

(UNAUDITED – IN MILLIONS)

THREE MONTHS ENDED JUNE 30, 2026 2025 % Change

Net investment (gains) losses $ 153 $ 421 (63.7) %

Items impacting net investment (gains) losses:

Amortized hedge costs (12) (11)

Amortized hedge income 19 30

Net interest income (expense) from derivatives associated

with certain investment strategies

(54) (64)

Impact of interest from derivatives associated with

notes payable1

— —

Adjusted net investment (gains) losses $ 106 $ 377 (71.9) %

1 Amounts are included with interest expenses that are a component of adjusted expenses.

RECONCILIATION OF NET INVESTMENT INCOME TO ADJUSTED NET INVESTMENT INCOME

(UNAUDITED – IN MILLIONS)

THREE MONTHS ENDED JUNE 30, 2026 2025 % Change

Net investment income $ 984 $ 1,081 (9.0) %

Items impacting net investment income:

Amortized hedge costs (12) (11)

Amortized hedge income 19 30

Net interest income (expense) from derivatives associated

with certain investment strategies

(54) (64)

Adjusted net investment income $ 937 $ 1,036 (9.6) %

RECONCILIATION OF NET INVESTMENT (GAINS) LOSSES TO ADJUSTED NET INVESTMENT (GAINS) LOSSES

(UNAUDITED – IN MILLIONS)

SIX MONTHS ENDED JUNE 30, 2026 2025 % Change

Net investment (gains) losses $ 104 $ 1,384 (92.5) %

Items impacting net investment (gains) losses:

Amortized hedge costs (27) (18)

Amortized hedge income 37 60

Net interest income (expense) from derivatives associated

with certain investment strategies

(111) (129)

Impact of interest from derivatives associated with

notes payable1

— 4

Adjusted net investment (gains) losses $ 3 $ 1,301 (99.8) %

1 Amounts are included with interest expenses that are a component of adjusted expenses.

RECONCILIATION OF NET INVESTMENT INCOME TO ADJUSTED NET INVESTMENT INCOME

(UNAUDITED – IN MILLIONS)

SIX MONTHS ENDED JUNE 30, 2026 2025 % Change

Net investment income $ 1,940 $ 2,036 (4.7) %

Items impacting net investment income:

Amortized hedge costs (27) (18)

Amortized hedge income 37 60

Net interest income (expense) from derivatives associated

with certain investment strategies

(111) (129)

Adjusted net investment income $ 1,839 $ 1,949 (5.6) %

RECONCILIATION OF U.S. GAAP BOOK VALUE TO ADJUSTED BOOK VALUE

(EXCLUDING FOREIGN CURRENCY REMEASUREMENT)

(UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)

JUNE 30, 2026 2025 % Change

U.S. GAAP book value $ 30,312 $ 27,200

Less:

Unrealized foreign currency translation gains (losses)

(5,048) (4,282)

Unrealized gains (losses) on securities and derivatives

(2,769) (1,845)

Effect of changes in discount rate assumptions 10,415 5,594

Pension liability adjustment

83 42

Total AOCI

2,681 (491)

Adjusted book value $ 27,631 $ 27,691

Less:

Foreign currency remeasurement gains (losses) 6,927 4,711

Adjusted book value excluding foreign currency remeasurement $ 20,704 $ 22,980

Number of outstanding shares at end of period (000) 502,257 534,809

U.S. GAAP book value per common share $ 60.35 $ 50.86 18.7 %

Less:

Unrealized foreign currency translation gains (losses) per common share

(10.05) (8.01)

Unrealized gains (losses) on securities and derivatives per common share

(5.51) (3.45)

Effect of changes in discount rate assumptions

per common share 20.74 10.46

Pension liability adjustment per common share

0.17 0.08

Total AOCI per common share

5.34 (0.92)

Adjusted book value per common share $ 55.01 $ 51.78 6.2 %

Less:

Foreign currency remeasurement gains (losses) per common share 13.79 8.81

Adjusted book value excluding foreign currency remeasurement per common share

$ 41.22 $ 42.97 (4.1) %

RECONCILIATION OF U.S. GAAP RETURN ON EQUITY (ROE) TO ADJUSTED ROE

(EXCLUDING IMPACT OF FOREIGN CURRENCY)

THREE MONTHS ENDED JUNE 30, 2026 2025

U.S. GAAP ROE - Net earnings1

10.9 % 9.0 %

Impact of excluding unrealized foreign currency translation gains (losses)

(2.0) (1.5)

Impact of excluding unrealized gains (losses) on securities and derivatives

(1.1) (0.5)

Impact of excluding effect of changes in discount rate assumptions 3.9 1.6

Impact of excluding pension liability adjustment

— —

Impact of excluding AOCI

0.9 (0.4)

U.S. GAAP ROE - less AOCI 11.9 8.6

Differences between adjusted earnings and net earnings2

0.8 5.1

Adjusted ROE - reported 12.7 13.7

Impact of excluding gains (losses) associated with foreign currency remeasurement3

3.9 2.9

Adjusted ROE, excluding foreign currency remeasurement 16.6 16.6

1 U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.

2 See separate reconciliation of net income to adjusted earnings.

3 Impact of gains/losses associated with foreign currency remeasurement is calculated by excluding the cumulative (beginning January 1, 2021) foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. The impact is the difference of adjusted return on equity - reported compared with adjusted return on equity, excluding from shareholders' equity, gains/losses associated with foreign currency remeasurement.

RECONCILIATION OF U.S. GAAP RETURN ON EQUITY (ROE) TO ADJUSTED ROE

(EXCLUDING IMPACT OF FOREIGN CURRENCY)

SIX MONTHS ENDED JUNE 30, 2026 2025

U.S. GAAP ROE - Net earnings1

12.3 % 4.7 %

Impact of excluding unrealized foreign currency translation gains (losses)

(2.2) (0.8)

Impact of excluding unrealized gains (losses) on securities and derivatives

(1.0) (0.2)

Impact of excluding effect of changes in discount rate assumptions 4.0 0.7

Impact of excluding pension liability adjustment

— —

Impact of excluding AOCI

0.9 (0.3)

U.S. GAAP ROE - less AOCI 13.2 4.4

Differences between adjusted earnings and net earnings2

(0.4) 8.7

Adjusted ROE - reported 12.8 13.1

Impact of excluding gains (losses) associated with foreign currency remeasurement3

3.9 3.0

Adjusted ROE, excluding foreign currency remeasurement 16.7 16.1

1 U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.

2 See separate reconciliation of net income to adjusted earnings.

EFFECT OF FOREIGN CURRENCY ON ADJUSTED RESULTS1

(SELECTED PERCENTAGE CHANGES, UNAUDITED)

THREE MONTHS ENDED JUNE 30, Including

Currency

Changes

Excluding

Currency

Changes2

Net earned premiums3

(6.3) % (1.1) %

Adjusted net investment income4

(9.6) (7.6)

Total benefits and expenses (6.5) (1.5)

Adjusted earnings (7.7) (4.9)

Adjusted earnings per diluted share (1.7) 1.1

1Refer to previously defined adjusted earnings and adjusted earnings per diluted share.

2Amounts excluding currency changes were determined using the same foreign currency exchange rate for the current period as the comparable period in the prior year, which eliminates dollar-based fluctuations driven solely from currency rate changes.

3Net of reinsurance

4Refer to previously defined adjusted net investment income.

EFFECT OF FOREIGN CURRENCY ON ADJUSTED RESULTS1

(SELECTED PERCENTAGE CHANGES, UNAUDITED)

SIX MONTHS ENDED JUNE 30, Including

Currency

Changes

Excluding

Currency

Changes2

Net earned premiums3

(4.2) % (0.9) %

Adjusted net investment income4

(5.6) (4.3)

Total benefits and expenses (4.5) (1.2)

Adjusted earnings (4.2) (2.4)

Adjusted earnings per diluted share 2.0 4.1

1Refer to previously defined adjusted earnings and adjusted earnings per diluted share.

3Net of reinsurance

4Refer to previously defined adjusted net investment income.

GLOSSARY OF OPERATIONAL MEASURES

The Company defines the operational measures included in this document as follows:

•Operating ratios are used to evaluate the Company's financial condition and profitability. Examples include: (1) Ratios to total adjusted revenues, which present expenses as percentage of total revenues and (2) Ratios to total premium, including benefit ratio. Operating ratios include: Benefit Ratio and Expense Ratio.

•New annualized premium sales are sometimes referred to as new sales or sales. An operating measure that is not reflected on the Company's financial statements. New annualized premium sales generally represent annual premiums on policies and riders the Company sold and incremental increases from policy conversions that would be collected over a 12-month period assuming the policies remain in force for that entire period. For Aflac Japan, new annualized premium sales are determined by applications submitted during the reporting period. For Aflac U.S., new annualized premium sales are determined by applications that are issued during the reporting period. Policy conversions are defined as the positive difference in the annualized premium when a policy upgrades in the current reporting period. The Company believes that this metric is a key indicator of the Company's future source of earnings.

•Premium persistency is the percentage of premiums remaining in force at the end of a period, usually one year, and presented on a trailing 12-month average basis. For example, 95% persistency would mean that 95% of the premiums in force at the beginning of a period are still in force at the end of the period. The Company believes that this metric is a key driver of in force levels, which is a key measure of the size of the Company's business and future sources of earnings.

FORWARD-LOOKING INFORMATION

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. Aflac Incorporated (the Parent Company) and its subsidiaries (collectively with the Parent Company, the Company) desire to take advantage of these provisions. This document contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by Company officials in communications with the financial community and contained in documents filed with or furnished to the Securities and Exchange Commission (SEC). Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks and uncertainties. In particular, statements containing words such as “expect,” “anticipate,” “believe,” “goal,” “objective,” "strategy," “may,” “should,” “estimate,” “intend,” “project,” "future," “will,” “assume,” “potential,” “target,” "outlook," "continue" or similar words as well as specific projections of future results, generally qualify as forward-looking. The Company undertakes no obligation to update such forward-looking statements, except as may be required by law.

The Company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements:

•difficult conditions in global capital markets and the economy, including inflation

•defaults and credit downgrades of investments

•global fluctuations in interest rates and exposure to significant interest rate risk

•concentration of business in Japan

•limited availability of acceptable Japanese yen-denominated investments

•foreign currency fluctuations in the yen/dollar exchange rate

•differing interpretations applied to investment valuations

•significant valuation judgments in determination of expected credit losses recorded on the Company's investments

•decreases in the Company's financial strength or debt ratings

•decline in creditworthiness of other financial institutions

•the Company's ability to attract and retain qualified sales associates, brokers, employees, and distribution partners

•deviations in actual experience from pricing and reserving assumptions

•ability to continue to develop and implement improvements in information technology systems and on successful execution of revenue growth and expense management initiatives

•interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality, integrity or privacy of sensitive data residing on such systems, and uncertainty regarding the impact of the

incident involving unauthorized access to the Company’s network in June 2025

•subsidiaries' ability to pay dividends to the Parent Company

•inherent limitations to risk management policies and procedures

•operational risks of third-party vendors

•tax rates applicable to the Company may change

•failure to comply with restrictions on policyholder privacy and information security

•extensive regulation and changes in law or regulation by governmental authorities

•competitive environment and ability to anticipate and respond to market trends

•catastrophic events, including, but not limited to, epidemics, pandemics, tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, major public health issues, terrorism or other acts of violence, and damage incidental to such events

•ability to protect the Aflac brand and the Company's reputation

•ability to effectively manage key executive succession

•changes in accounting standards

•level and outcome of litigation or regulatory inquiries

•allegations or determinations of worker misclassification in the United States

Analyst and investor contact - David A. Young, 706.596.3264; 800.235.2667 or aflacir@aflac.com

Media contact - Ines Gutzmer, 762.207.7601 or igutzmer@aflac.com

EX-99.2

Filename: afl063026-financialsupplem.htm · Sequence: 3

Document

Final 08/06/2026

Financial Supplement

Second Quarter 2026

This document is a statistical supplement to Aflac’s quarterly earnings release. Throughout the presentation, amounts presented may not foot due to rounding. As you review the supplement, please note the non-U.S. GAAP financial measures and definitions found at the back of this document.

The Company adopted the Financial Accounting Standards Board’s Accounting Standard Update 2018-12 Financial Services - Insurance: Targeted Improvements to the Accounting for Long-Duration Contracts, as clarified and amended by (i) ASU 2019-09 Financial Services - Insurance: Effective Date, and (ii) ASU 2020-11 Financial Services - Insurance: Effective Date and Early Application (collectively, “LDTI”) as of January 1, 2023. The amended guidance is applied as of the beginning of the earliest period presented in the Company’s quarterly and annual financial statements, which results in a January 1, 2021 Transition Date. In conjunction with the adoption of LDTI, the Company changed its practice of recording the change in the deferred profit liability (DPL) on products with limited-payment features from the benefits and claims, net line item to the net earned premiums line item in the consolidated statement of earnings. This change in presentation has no impact on net earnings. All quarterly and annual amounts for 2021 and 2022 presented herein reflect these changes for LDTI and DPL.

Aflac Incorporated: Page

Share Data

Summary of Adjusted Results by Business Segment

Statements of Earnings

Analysis of Net Earnings and Net Earnings Per Share

Balance Sheets

Quarterly Financial Results

Quarterly Book Value Per Share

Return on Equity

Adjusted Earnings Per Share Excluding Current Period Foreign Currency Impact

Investment Results

11,12,13

Long-Term Debt Data

Ratings

Aflac U.S.:

Statement of Pretax Adjusted Earnings

Balance Sheets

Quarterly Pretax Adjusted Earnings

Operating Ratios

Sales

20,21

Aflac Japan:

Statement of Pretax Adjusted Earnings

22,23

Balance Sheets

24,25

Quarterly Pretax Adjusted Earnings

Operating Ratios

Sales

28,29,30

Yen/Dollar Exchange Rates

Corporate and Other:

Statement of Pretax Adjusted Earnings

Non-U.S. GAAP Financial Measures

For more information, contact:

David Young

Phone. 706.596.3264

Aflacir@aflac.com

investors.aflac.com

Aflac Incorporated and Subsidiaries

Share Data

(In Thousands)

1 Shares Issued Shares Purchased QTD Weighted Avg. Shares YTD Weighted Avg. Shares

Period Beginning Shares Outstanding Stk. Bon. & DRP Stk. Opt. & Misc. Treas. Shares

Misc. Purch. (1)

Ending Shares Outstanding Avg. Shares Dilutive Shares Avg. Diluted Avg. Shares Dilutive Shares Avg. Diluted

2024 1 578,479 212 1,320 9,276 457 570,278 574,886 2,596 577,482 574,886 2,596 577,482

2 570,278 217 186 9,288 24 561,369 564,573 2,265 566,838 569,730 2,430 572,160

3 561,369 165 75 4,882 10 556,717 557,899 2,515 560,414 565,757 2,459 568,216

4 556,717 156 77 6,982 4 549,964 552,767 2,716 555,483 562,492 2,523 565,015

2025 1 549,964 173 1,251 8,497 398 542,493 544,707 2,171 546,878 544,707 2,171 546,878

2 542,493 193 42 7,916 4 534,809 536,688 1,737 538,425 540,676 1,954 542,630

3 534,809 171 66 9,331 5 525,710 530,050 1,965 532,015 537,095 1,957 539,052

4 525,710 161 72 7,250 3 518,690 520,394 2,099 522,493 532,885 1,993 534,878

2026 1 518,690 160 1,046 9,013 353 510,530 513,071 1,715 514,785 513,071 1,715 514,785

2 510,530 168 84 8,521 4 502,257 504,123 1,455 505,578 508,572 1,578 510,150

(1) Includes previously owned shares used to purchase options (swapped shares) and/or shares purchased for deferred compensation program

Aflac Incorporated and Subsidiaries

Summary of Adjusted Results by Business Segment

(In Millions, except per-share data)

Years Ended December 31, 3 Months Ended June 30, 6 Months Ended June 30,

2021 2022 2023 2024 2025 2025 2026 % Change 2025 2026 % Change

Aflac Japan $ 3,756 $ 3,281 $ 3,234 $ 3,494 $ 3,440 $ 790 $ 741 (6.2) % $ 1,512 $ 1,500 (0.8) %

Aflac U.S. 1,356 1,359 1,501 1,419 1,421 388 370 (4.6) 746 733 (1.7)

Corporate and other (1)

(293) (218) (425) 32 101 20 (10) 63 (10)

Pretax adjusted earnings 4,819 4,422 4,310 4,945 4,962 1,198 1,101 (8.1) 2,321 2,223 (4.2)

Income taxes (1)

893 808 577 873 954 241 218 (9.5) 458 439 (4.1)

Adjusted earnings (2)

3,925 3,614 3,733 4,072 4,008 957 883 (7.7) 1,863 1,784 (4.2)

Reconciling items:

Adjusted net investment gains (losses) 462 447 914 1,495 (375) (377) (106) (1,301) (3)

Other and non-recurring income (loss)

(73) 1 39 (23) (54) — — (53) —

Income tax benefit (expense) on items excluded from adjusted earnings (3)

(83) 357 (26) (101) 67 19 48 119 63

Net earnings $ 4,231 $ 4,418 $ 4,659 $ 5,443 $ 3,646 $ 599 $ 825 37.7 % $ 628 $ 1,844 193.6 %

Effective Tax rate 18.7 % 9.3 % 11.5 % 15.2 % 19.6 % 27.0 % 17.0 % 35.0 % 16.9 %

Earnings per share of common stock:

Net earnings (basic) $ 6.28 $ 6.96 $ 7.81 $ 9.68 $ 6.84 $ 1.12 $ 1.64 46.4 $ 1.16 $ 3.63 212.9 %

Net earnings (diluted) 6.25 6.93 7.78 9.63 6.82 1.11 1.63 46.8 1.16 3.61 211.2

Adjusted earnings (basic) (2)

$ 5.83 $ 5.69 $ 6.26 $ 7.24 $ 7.52 $ 1.78 $ 1.75 (1.7) % $ 3.45 $ 3.51 1.7 %

Adjusted earnings (diluted) (2)

5.80 5.67 6.23 7.21 7.49 1.78 1.75 (1.7) 3.43 3.50 2.0

(1) The change in value of federal historic rehabilitation and solar investments in partnerships of $6 and $8 for the three-month periods ended June 30, 2026, and 2025, respectively, is included as a reduction to net investment income. Tax credits on these investments of $5 and $9 for the three-month periods ended June 30, 2026, and 2025, respectively, have been recorded as an income tax benefit in the consolidated statement of earnings.

(2) See non-U.S. GAAP financial measures for definition of adjusted earnings.

(3) Primarily reflects release of $452 in deferred taxes in 2022.

Aflac Incorporated and Subsidiaries

Consolidated Statements of Earnings - U.S. GAAP

(In Millions, except per-share data)

Years Ended December 31, 3 Months Ended June 30, 6 Months Ended June 30,

2021 2022 2023 2024 2025 2025 2026 % Change 2025 2026 % Change

Revenues:

Net earned premiums:

Gross premiums $ 17,305 $ 15,025 $ 14,318 $ 13,562 $ 13,760 $ 3,525 $ 3,364 $ 6,958 $ 6,785

Assumed (ceded) (210) (124) (195) (122) (212) (55) (112) (107) (223)

Total net earned premiums (1)

17,095 14,901 14,123 13,440 13,548 3,470 3,252 (6.3) % 6,851 6,562 (4.2) %

Net investment income 3,818 3,656 3,811 4,116 4,076 1,081 984 (9.0) 2,036 1,940 (4.7)

Net investment gains (losses)

468 363 590 1,271 (572) (421) (153) (1,384) (104)

Other income

173 220 177 100 112 30 34 55 65

Total revenues 21,554 19,140 18,701 18,927 17,164 4,160 4,117 (1.0) 7,558 8,463 12.0

Benefits and Claims:

Benefits and claims, net:

Incurred claims -direct 8,949 8,271 8,005 8,281 8,901 2,135 2,160 4,523 4,574

Incurred claims -assumed (ceded) (147) (108) (177) (95) (189) (51) (61) (95) (124)

Increase in FPB -direct (2)

1,819 888 594 (184) (727) (38) (183) (395) (602)

Increase in FPB -assumed (ceded) (2)

3 51 172 5 2 1 (18) — (36)

Total net benefits and claims, excluding reserve remeasurement 10,623 9,102 8,594 8,008 7,987 2,047 1,898 4,033 3,812

Reserve remeasurement (gain) loss (147) (215) (383) (558) (694) (37) (46) (78) (128)

Total net benefits and claims 10,476 8,887 8,211 7,450 7,293 2,010 1,852 (7.9) 3,955 3,684 (6.9)

Acquisition and operating expenses:

Amortization of DAC (3)

835 792 816 851 874 221 218 437 439

Insurance commissions 1,256 1,117 1,052 998 991 251 239 491 476

Insurance expenses 3,541 3,249 3,165 3,014 3,253 804 749 1,606 1,520

Interest expense 238 226 195 197 220 52 64 102 124

Total acquisition and operating expenses 5,870 5,384 5,228 5,060 5,338 1,328 1,270 (4.4) 2,636 2,559 (2.9)

Total benefits and expenses 16,346 14,271 13,439 12,510 12,631 3,338 3,122 (6.5) 6,591 6,243 (5.3)

Pretax earnings 5,208 4,869 5,262 6,417 4,533 822 995 967 2,220

Income tax expense (benefit) (4)

977 451 603 974 887 223 170 339 376

Net earnings $ 4,231 $ 4,418 $ 4,659 $ 5,443 $ 3,646 $ 599 $ 825 37.7 % $ 628 $ 1,844 193.6 %

(1) Includes a gain (loss) of an immaterial amount for the three-month periods ended June 30, 2026 and 2025, respectively, related to remeasurement of the deferred profit liability for limited- payment contracts.

(2) Future policy benefits

(3) Deferred acquisition costs

(4) Primarily reflects release of $452 in deferred taxes in 2022.

Aflac Incorporated and Subsidiaries

Analysis of Net Earnings and Net Earnings Per Diluted Share

(In Millions, except for per-share data)

Period Net Earnings

Net Investment Gains (Losses) (1)

Other and Non- Recurring Items (1)

Foreign Currency Impact (2)

Net Earnings Per Share

Net Investment Gains (Losses) (1)

Other and Non-Recurring Items Per Share (1)

Foreign Currency Impact Per Share (2)

1 2021 $ 4,231 $ 365 $ (59) $ (42) $ 6.25 $ 0.54 $ (0.09) $ (0.06)

2 2022 4,418 803 1 (262) 6.93 1.26 — (0.41)

2023 4,659 896 31 (113) 7.78 1.50 0.05 (0.19)

2024 5,443 1,389 (18) (103) 9.63 2.46 (0.03) (0.18)

2025 3,646 (319) (43) 19 6.82 (0.60) (0.08) 0.04

2024 1 1,879 920 (2) (44) 3.25 1.59 — (0.08)

2 1,755 720 — (37) 3.10 1.27 — (0.07)

3 (93) (1,304) — (16) (0.17) (2.33) — (0.03)

4 1,902 1,054 (17) (6) 3.42 1.90 (0.03) (0.01)

2025 1 29 (835) (42) (8) 0.05 (1.53) (0.08) (0.01)

2 599 (358) — 23 1.11 (0.66) — 0.04

3 1,639 313 (1) 1 3.08 0.59 — —

4 1,379 561 — (1) 2.64 1.07 — —

2026 1 1,019 118 — (8) 1.98 0.23 — (0.02)

2 825 (58) — (27) 1.63 (0.11) — (0.05)

(1) Items are presented net of tax.

(2) See non-U.S. GAAP financial measures for definition of adjusted earnings excluding current period foreign currency impact

Aflac Incorporated and Subsidiaries

Consolidated Balance Sheets

(In Millions, except per-share data)

December 31, June 30,

2021 2022 2023 2024 2025 2025 2026

Assets:

Investments and cash:

Securities available for sale:

Fixed maturity securities available for sale, at fair value $ 94,206 $ 71,936 $ 69,578 $ 61,841 $ 60,485 $ 65,204 $ 58,640

Fixed maturity securities available for sale - consolidated variable interest entities, at fair value 4,490 3,805 3,712 3,428 3,636 3,675 4,208

Fixed maturity securities held to maturity, at amortized cost, net of allowance for credit losses 22,000 19,056 17,819 15,966 16,120 17,434 15,505

Equity securities, at fair value 1,603 1,091 1,088 796 887 882 925

Commercial mortgage and other loans, net of allowance for credit losses 11,786 13,496 12,527 10,869 9,765 10,264 9,354

Other investments 3,842 4,070 4,530 5,958 6,622 7,345 8,251

Cash and cash equivalents 5,051 3,943 4,306 6,229 6,245 6,965 6,120

Total investments and cash 142,978 117,397 113,560 105,087 103,760 111,769 103,003

Receivables, net of allowance for credit losses (1)

672 647 848 779 835 873 895

Accrued investment income 737 745 731 710 718 753 733

Deferred policy acquisition costs 9,848 9,239 9,132 8,758 9,034 9,296 8,948

Property and equipment, net 538 530 445 387 351 390 351

Other assets, net of allowance for credit losses (1)(2)

3,377 3,180 2,008 1,845 1,772 1,655 2,031

Total assets $ 158,150 $ 131,738 $ 126,724 $ 117,566 $ 116,470 $ 124,736 $ 115,961

Liabilities and Shareholders' Equity:

Liabilities:

Total policy liabilities $ 126,331 $ 96,910 $ 91,599 $ 77,508 $ 69,583 $ 78,904 $ 64,348

Notes payable 7,956 7,442 7,364 7,498 8,409 8,933 8,729

Income taxes, primarily deferred 30 698 154 573 1,368 685 1,589

Other liabilities 6,802 6,548 5,622 5,889 7,620 9,014 10,983

Total liabilities 141,119 111,598 104,739 91,468 86,980 97,536 85,649

Shareholders' equity:

Common stock 135 135 136 136 136 136 136

Additional paid-in capital 2,529 2,641 2,771 2,894 3,024 2,958 3,105

Retained earnings 40,963 44,367 47,993 52,277 54,682 52,595 56,218

Accumulated other comprehensive income (loss):

Unrealized foreign currency translation gains (losses) (1,985) (3,564) (4,069) (4,998) (4,847) (4,282) (5,048)

Unrealized gains (losses) on fixed maturity securities 9,602 (702) 1,139 24 (1,809) (1,828) (2,753)

Unrealized gains (losses) on derivatives (30) (27) (22) (20) (13) (17) (16)

Effect of change in discount rate assumption(s) (15,832) (2,100) (2,560) 2,006 8,035 5,594 10,415

Pension liability adjustment (166) (36) (8) 10 86 42 83

Treasury stock (18,185) (20,574) (23,395) (26,231) (29,804) (27,998) (31,828)

Total shareholders' equity 17,031 20,140 21,985 26,098 29,490 27,200 30,312

Total liabilities and shareholders' equity $ 158,150 $ 131,738 $ 126,724 $ 117,566 $ 116,470 $ 124,736 $ 115,961

(1) Certain reclassifications have been made to prior-year amounts to conform to current-year reporting classifications. These reclassifications had no impact on net earnings or total shareholders' equity.

(2) Includes goodwill of $261 million in June 2026, $260 million in June 2025, $260 million in 2025, $263 million in 2024, $265 million in 2023, $265 million in 2022 and $268 million in 2021

Aflac Incorporated and Subsidiaries

Quarterly Financial Results

(In Millions, except per-share data)

1 Net EPS

Adj. EPS (1)

Period Net Earned Premiums Net Investment Income Total Revenues Benefits & Claims, Net Total Acquisitions & Adj. Exp. Total Pretax Earnings Net Earnings

Adjusted Earnings (1)

Basic Dil. Basic Dil.

2021 $ 17,095 $ 3,818 $ 21,554 $ 10,476 $ 5,870 $ 5,208 $ 4,231 $ 3,925 $ 6.28 $ 6.25 $ 5.83 $ 5.80

2022 14,901 3,656 19,140 8,887 5,384 4,869 4,418 3,614 6.96 6.93 5.69 5.67

2023 14,123 3,811 18,701 8,211 5,228 5,262 4,659 3,733 7.81 7.78 6.26 6.23

2024 13,440 4,116 18,927 7,450 5,060 6,417 5,443 4,072 9.68 9.63 7.24 7.21

2025 13,548 4,076 17,164 7,293 5,338 4,533 3,646 4,008 6.84 6.82 7.52 7.49

2024 1 3,456 1,000 5,436 2,010 1,256 2,170 1,879 961 3.27 3.25 1.67 1.66

2 3,325 1,095 5,138 1,921 1,198 2,019 1,755 1,035 3.11 3.10 1.83 1.83

3 3,328 1,006 2,949 1,595 1,262 92 (93) 1,211 (0.17) (0.17) 2.17 2.16

4 3,331 1,016 5,403 1,923 1,345 2,135 1,902 865 3.44 3.42 1.56 1.56

2025 1 3,381 955 3,398 1,945 1,308 145 29 906 0.05 0.05 1.66 1.66

2 3,470 1,081 4,160 2,010 1,328 822 599 957 1.12 1.11 1.78 1.78

3 3,372 1,067 4,740 1,436 1,310 1,994 1,639 1,327 3.09 3.08 2.50 2.49

4 3,325 973 4,866 1,902 1,392 1,572 1,379 818 2.65 2.64 1.57 1.57

2026 1 3,310 956 4,346 1,832 1,289 1,225 1,019 901 1.99 1.98 1.76 1.75

2 3,252 984 4,117 1,852 1,270 995 825 883 1.64 1.63 1.75 1.75

(1) See non-U.S. GAAP financial measures for definition of adjusted earnings.

Aflac Incorporated and Subsidiaries

Quarterly Book Value Per Share

(In Millions, except per-share data)

Period Equity BV Per Share AOCI BV Per Share

Adjusted BV Per Share (1)

Adjusted BV Per Share

% Change

Adjusted BV Per Share Excluding Foreign Currency Remeasurement

G/(L) (1)(2)

Adjusted BV Per Share Excluding Foreign Currency Remeasurement

G/(L) % Change (2)

2021 $ 26.12 $ (12.90) $ 39.01 9.7 % $ 37.71 6.0 %

2022 32.73 (10.45) 43.18 10.7 38.94 3.3

2023 38.00 (9.54) 47.55 10.1 41.15 5.7

2024 47.45 (5.41) 52.87 11.2 42.46 3.2

2025 56.85 2.80 54.06 2.3 42.66 0.5

2024 1 41.27 (8.95) 50.22 12.4 41.68 4.1

2 46.40 (5.86) 52.26 12.1 41.98 4.6

3 44.60 (6.60) 51.21 5.7 43.61 6.1

4 47.45 (5.41) 52.87 11.2 42.46 3.2

2025 1 48.55 (3.43) 51.98 3.5 42.61 2.2

2 50.86 (0.92) 51.78 (0.9) 42.97 2.4

3 54.57 1.24 53.33 4.1 43.52 (0.2)

4 56.85 2.80 54.06 2.3 42.66 0.5

2026 1 58.69 3.72 54.96 5.7 42.71 0.2

2 60.35 5.34 55.01 6.2 41.22 (4.1)

(1) See non-U.S. GAAP financial measures for definition of adjusted book value and adjusted book value excluding foreign currency remeasurement

(2) Due to a calculation error, we have corrected the Adjusted BV Per Share Excluding Foreign Currency Remeasurement G/(L) and percentage changes for Q2 and Q3 2025.

Aflac Incorporated and Subsidiaries

Return on Equity

Year ended December 31, 3 Months Ended June 30, 6 Months Ended June 30,

2021 (4)

2022

2023

2024

2025 2025 2026 2025 2026

U.S. GAAP ROE - Net earnings (1)

26.7 % 23.8 % 22.1 % 22.6 % 13.1 % 9.0 % 10.9 % 4.7 % 12.3 %

Impact of excluding unrealized foreign currency translation gains (losses) (1.7) (2.5) (3.1) (3.6) (2.6) (1.5) (2.0) (0.8) (2.2)

Impact of excluding unrealized gains (losses) on securities and derivatives 10.7 4.1 0.2 0.4 (0.5) (0.5) (1.1) (0.2) (1.0)

Impact of excluding effect on change in discount rate assumptions (18.5) (8.2) (1.9) (0.2) 2.6 1.6 3.9 0.7 4.0

Impact of excluding pension liability adjustment (0.2) (0.1) — — — — — — —

Impact of excluding AOCI (9.7) (6.8) (4.9) (3.4) (0.4) (0.4) 0.9 (0.3) 0.9

U.S. GAAP ROE - less AOCI 17.0 17.0 17.2 19.2 12.8 8.6 11.9 4.4 13.2

Differences between adjusted earnings and net earnings (2)

(1.2) (3.1) (3.4) (4.8) 1.3 5.1 0.8 8.7 (0.4)

Adjusted ROE - reported (3)

15.8 13.9 13.8 14.4 14.0 13.7 12.7 13.1 12.8

Less: Impact of excluding gains (losses) associated with foreign currency remeasurement (5)

— 1.0 1.8 2.9 3.6 2.9 3.9 3.0 3.9

Adjusted ROE, excluding foreign currency remeasurement (5)(6)

16.0 14.9 15.6 17.3 17.6 16.6 16.6 16.1 16.7

(1) U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.

(2) See separate reconciliation of net income to adjusted earnings.

(3) See non-U.S. GAAP financial measures for definition of adjusted return on equity

(4) Return on equity calculations for 2021 use beginning retained earnings and accumulated other comprehensive income adjusted for the adoption of LDTI.

(5) Impact of gains/losses associated with foreign currency remeasurement is calculated by excluding the cumulative (beginning January 1, 2021) foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. The impact is the difference of adjusted return on equity - reported compared with adjusted return on equity, excluding from shareholders' equity, gains/losses associated with foreign currency remeasurement

(6) Due to a calculation error, we have corrected the adjusted return on equity excluding foreign currency remeasurement for Q2 and Q3 2025.

Aflac Incorporated and Subsidiaries

Adjusted Earnings Per Share Excluding Current Period Foreign Currency Impact (1)

(Diluted Basis)

1 Period

Adjusted EPS (1)

Growth

QTD Foreign Currency Impact (1)

YTD Foreign Currency Impact (1)

Excluding Foreign Currency Impact (1)

Change Excluding Foreign Currency Impact

2021 $ 5.80 16.9 % N/A (0.06) $ 5.86 18.1 %

2022 5.67 (2.2) N/A (0.41) 6.08 4.8

2023 6.23 9.9 N/A (0.19) 6.43 13.4

2024 7.21 15.7 N/A (0.18) 7.39 18.6

2025 7.49 3.9 N/A 0.04 7.46 3.5

2024 1 $ 1.66 7.1 % (0.08) (0.08) $ 1.74 12.3 %

2 1.83 15.8 (0.07) (0.14) 1.89 19.6

3 2.16 17.4 (0.03) (0.17) 2.19 19.0

4 1.56 24.8 (0.01) (0.18) 1.57 25.6

$ 7.21 15.7 % $ 7.39 18.6 %

2025 1 $ 1.66 — % (0.01) (0.01) $ 1.67 0.6 %

2 1.78 (2.7) 0.04 0.03 1.73 (5.5)

3 2.49 15.3 — 0.03 2.49 15.3

4 1.57 0.6 — 0.04 1.57 0.6

$ 7.49 3.9 % $ 7.46 3.5 %

2026 1 1.75 5.4 (0.02) (0.02) 1.77 6.6

2 1.75 (1.7) (0.05) (0.07) 1.80 1.1

$ 3.50 2.0 % $ 3.57 4.1 %

(1) See non-U.S.GAAP financial measures for definition of adjusted earnings and adjusted earnings excluding current period foreign currency impact

Aflac Incorporated and Subsidiaries

Composition of Invested Assets

(In Millions)

December 31, June 30,

2021 2022 2023 2024 2025 2025 2026

Fixed Maturity Securities

$ 107,369 $ 94,525 $ 88,508 $ 80,055 $ 81,383 $ 87,464 $ 80,695

Commercial mortgage and other loans, net of allowance for credit losses:

Transitional Real Estate (floating rate) 5,246 6,455 5,998 4,703 3,611 4,115 3,029

Middle Market Loans (floating rate) 4,601 5,028 4,531 4,283 4,266 4,228 4,388

Commercial Mortgage Loans 1,854 1,775 1,697 1,523 1,443 1,478 1,362

Other Loans 20 238 301 360 445 443 575

Total Commercial mortgage and other loans, net of allowance for credit losses

11,721 13,496 12,527 10,869 9,765 10,264 9,354

Equity Securities, at FV through net earnings 1,603 1,091 1,088 796 887 882 925

Alternatives (1)

1,703 2,107 2,619 3,167 3,809 3,464 4,052

Total Portfolio $ 122,396 $ 111,219 $ 104,742 $ 94,887 $ 95,844 $ 102,074 $ 95,026

Unrealized Gains (Losses) on Invested Assets

(In Millions)

December 31, June 30,

2021 2022 2023 2024 2025 2025 2026

Fixed Maturity Securities:

Available For Sale - Gross Gains $ 13,566 $ 4,800 $ 6,050 $ 5,308 $ 4,782 $ 4,072 $ 4,289

Available For Sale - Gross Losses (239) (4,528) (3,449) (4,128) (5,924) (5,223) (6,631)

Total Available For Sale 13,327 272 2,601 1,180 (1,142) (1,151) (2,342)

Held to Maturity - Gross Gains 4,869 2,154 1,838 815 87 446 8

Held to Maturity - Gross Losses — — — (9) (731) (273) (1,257)

Total Held to Maturity $ 4,869 $ 2,154 $ 1,838 $ 806 $ (644) $ 173 $ (1,249)

Credit Ratings on Fixed Maturities

(At Amortized Cost)

December 31, June 30,

Credit Rating: 2021 2022 2023 2024 2025 2025 2026

AAA 1.0 % 1.6 % 1.6 % 1.5 % 1.1 % 1.4 % 1.3 %

AA 5.1 5.2 5.7 6.0 6.6 6.3 7.0

A 68.9 68.0 68.1 68.0 69.0 68.5 69.0

BBB 22.5 23.0 22.9 22.9 21.9 22.2 21.4

BB or Lower 2.5 2.2 1.7 1.6 1.4 1.6 1.3

100.0 % 100.0 % 100.0 % 100.0 % 100.0 % 100.0 % 100.0 %

(1) Presented at carrying value; includes asset classes such as private equity and real estate funds managed by Global Investments; excludes Corporate driven activity, policy loans, short-term investments, real estate owned assets and FHLB equity balances

Aflac Incorporated and Subsidiaries

Supplemental Investment Data by Segment

December 31, 3 Months Ended June 30, 6 Months Ended June 30,

2021 2022 2023 2024 2025 2025 2026 2025 2026

Aflac Japan:

Invested assets (in millions) (1)

¥ 12,405,531 ¥ 12,617,181 ¥ 12,127,531 ¥ 11,881,515 ¥ 11,994,018 ¥ 12,064,994 ¥ 12,390,818 ¥ 12,064,994 ¥ 12,390,818

Return on average invested assets (2)

2.72 % 2.78 % 2.90 % 3.33 % 3.22 % 3.38 % 3.18 % 3.19 % 3.12 %

Portfolio book yield at end of period (3)

2.60 % 3.06 % 3.18 % 3.22 % 3.26 % 3.26 % 3.39 % 3.26 % 3.39 %

Total purchases for period (in millions) (3)

¥ 952,038 ¥ 716,964 ¥ 378,541 ¥ 735,141 ¥ 1,744,625 ¥ 383,204 ¥ 692,785 ¥ 1,353,009 ¥ 1,041,543

New money yield (3)(4)

3.50 % 4.48 % 5.18 % 6.11 % 4.17 % 5.26 % 4.19 % 3.85 % 4.45 %

Aflac U.S.:

Invested assets (in millions) (1)

$ 15,841 $ 16,772 $ 17,075 $ 17,341 $ 17,373 $ 17,279 $ 18,073 $ 17,279 $ 18,073

Return on average invested assets (2)

4.87 % 4.72 % 4.88 % 5.00 % 4.94 % 4.94 % 4.98 % 4.92 % 4.96 %

Portfolio book yield at end of period (3)

4.94 % 5.39 % 5.53 % 5.58 % 5.47 % 5.57 % 5.51 % 5.57 % 5.51 %

Total purchases for period (in millions) (3)

$ 2,130 $ 1,701 $ 907 $ 934 $ 1,156 $ 327 $ 693 $ 819 $ 1,371

New money yield (3)(4)

3.41 % 5.16 % 7.56 % 6.90 % 6.73 % 6.97 % 6.37 % 6.75 % 6.30 %

(1) Invested assets, including cash and short term investments, are stated at amortized cost; except for equities, which are at fair value.

(2) Net of investment expenses and amortized hedge costs, year-to-date number reflected on a quarterly average basis.

(3) Includes fixed maturity securities, commercial mortgage and other loans, equity securities, and excludes alternative investments in limited partnerships, and any impacts from hedging activities.

(4) Reported on a gross yield basis; excludes investment expenses, external management fees, and amortized hedge costs.

Aflac Incorporated and Subsidiaries

Japan Segment Portfolio Allocation by Currency (1)

(U.S. GAAP Basis)

(In Millions)

December 31, 2025 June 30, 2026

Amortized Cost (2)

Fair Value

Amortized Cost (2)

Fair Value

JGB $ 30,698 $ 27,313 $ 27,275 $ 23,154

Other 16,870 16,036 18,123 16,721

Total yen denominated 47,568 43,349 45,398 39,875

USD Program 23,503 25,855 25,382 27,631

Other 1,632 2,398 1,613 2,408

Total US dollar denominated 25,135 28,253 26,995 30,039

Total $ 72,703 $ 71,602 $ 72,393 $ 69,914

Distribution of Consolidated Fixed Maturities by Sector

(In millions)

June 30, 2026

Amortized Cost (2)

% of Total

Government and agencies $ 32,488 40.3 %

Municipalities 2,136 2.6

Mortgage- and asset-backed securities 5,553 6.9

Public utilities: 6,807 8.5

Electric 5,390 6.7

Natural Gas 874 1.1

Other 543 0.7

Sovereign and supranational 706 0.9

Banks/financial institutions: 9,230 11.3

Banking 5,189 6.3

Insurance 1,798 2.2

Other 2,243 2.8

Other corporate: 23,775 29.5

Basic Industry 1,978 2.4

Capital Goods 2,776 3.4

Communications 2,490 3.1

Consumer Cyclical 1,861 2.3

Consumer Non-Cyclical 5,375 6.7

Energy 2,548 3.2

Other 1,012 1.3

Technology 3,086 3.8

Transportation 2,649 3.3

Total fixed maturity securities $ 80,695 100.0 %

(1) Non-U.S.dollar-denominated investments in the U.S. segment are immaterial.

(2) Net of reserves

Aflac Incorporated and Subsidiaries

Long-Term Debt Data

Adjusted Leverage Ratios

(In Millions)

December 31, June 30,

2021 2022 2023 2024 2025 2025 2026

Notes payable $ 7,956 $ 7,442 $ 7,364 $ 7,498 $ 8,409 $ 8,933 $ 8,729

50% of subordinated debentures and perpetual bonds (389) (337) (315) (282) (285) (308) (275)

Pre-funding of debt maturities — — (211) — (399) (486) (668)

Adjusted debt (1)

7,568 7,105 6,839 7,216 7,725 8,139 7,786

Total Shareholders' Equity 17,031 20,140 21,985 26,098 29,490 27,200 30,312

Accumulated other comprehensive (income) loss:

Unrealized foreign currency translation (gains) losses 1,985 3,564 4,069 4,998 4,847 4,282 5,048

Unrealized (gains) losses on fixed maturity securities (9,602) 702 (1,139) (24) 1,809 1,828 2,753

Unrealized (gains) losses on derivatives 30 27 22 20 13 17 16

Effect on change in discount rate assumptions 15,832 2,100 2,560 (2,006) (8,035) (5,594) (10,415)

Pension liability adjustment 166 36 8 (10) (86) (42) (83)

Adjusted book value (1)

$ 25,442 $ 26,569 $ 27,505 $ 29,076 $ 28,038 $ 27,691 $ 27,631

Total capitalization (5)

$ 24,987 $ 27,582 $ 29,349 $ 33,596 $ 37,899 $ 36,133 $ 39,041

Debt to capitalization 31.8 % 27.0 % 25.1 % 22.3 % 22.2 % 24.7 % 22.4 %

Adjusted capitalization ex-AOCI (1)(2)

$ 33,398 $ 34,011 $ 34,658 $ 36,574 $ 36,048 $ 36,138 $ 35,692

Adjusted debt to adjusted capitalization ex-AOCI 22.7 % 20.9 % 19.7 % 19.7 % 21.4 % 22.5 % 21.8 %

Adjusted capitalization (1)(3)

$ 31,247 $ 30,411 $ 30,581 $ 31,586 $ 31,287 $ 31,898 $ 30,727

Adjusted debt to adjusted capitalization 24.2 % 23.4 % 22.4 % 22.8 % 24.7 % 25.5 % 25.3 %

Debt Maturities Remaining (4)

(In Millions)

June 30, 2026

2026 2027-2031 2032-2036 2037-2046 2047+ Total

Senior Notes $ 300 $ 3,130 $ 2,476 $ 1,370 $ 867 $ 8,143

Subordinated debt 554 554

Total $ 300 $ 3,130 $ 2,476 $ 1,370 $ 1,421 $ 8,697

(1) See non-U.S. GAAP financial measures for definition of: adjusted debt; adjusted book value; adjusted debt, including 50% of subordinated debentures and perpetual bonds; and adjusted book value, including unrealized foreign currency translation gains and losses and pension liability adjustment

(2) Adjusted capitalization ex-AOCI is the sum of adjusted debt, including 50% of subordinated debentures and perpetual bonds, plus adjusted book value

(3) Adjusted capitalization is sum of adjusted debt, including 50% of subordinated debentures and perpetual bonds, plus adjusted book value, including unrealized foreign currency translation gains and losses and pension liability adjustment

(4) Debt maturity amounts do not include discounts, premiums, deferred charges, or capital lease obligations.

(5) Total capitalization is sum of notes payable and shareholders' equity.

Aflac Incorporated and Subsidiaries

Insurer Financial Strength Ratings

AM Best Moody's S&P JCR R&I

U.S. Operating Companies:

Aflac of Columbus A+ Aa3 A+ AA+ AA

Aflac of New York A+ _ A+ _ _

Continental American Insurance Company A+ _ _ _ _

Japan Operating Company:

Aflac Life Insurance Japan Ltd. A+ Aa3 A+ AA+ AA

Bermuda Operating Company:

Aflac Re Bermuda Ltd. _ _ _ AA+ _

Issuer Credit Ratings

AM Best Moody's S&P JCR R&I

Aflac Incorporated:

Long-term Senior Debt a A3 A- AA- A+

Junior Subordinated Debt a- Baa1 BBB _ A-

Aflac of Columbus:

Long-term Senior Debt aa _ A+ AA+ _

Aflac Life Insurance Japan, Ltd.:

Long-term Senior Debt aa _ A+ AA+ _

The outlook for all ratings is stable.

Aflac U.S.

Statements of Pretax Adjusted Earnings

(Before Management Fee)

(In Millions)

Years Ended December 31, 3 Months Ended June 30, 6 Months Ended June 30,

2021 2022 2023 2024 2025 2025 2026 % Change 2025 2026 % Change

Revenues:

Net earned premiums:

Gross premiums $ 5,540 $ 5,467 $ 5,669 $ 5,907 $ 6,182 $ 1,548 $ 1,609 $ 3,091 $ 3,233

Assumed (ceded) 73 103 6 (78) (183) (44) (70) (85) (139)

Total net earned premiums 5,614 5,570 5,675 5,829 5,999 1,504 1,539 2.3 % 3,006 3,094 2.9 %

Adjusted net investment income 754 755 820 847 830 207 208 0.5 409 409 —

Other income excl. realized foreign exchange gains (losses) 121 161 128 63 74 17 24 34 47

Total adjusted revenues 6,489 6,486 6,623 6,739 6,903 1,728 1,771 2.5 3,449 3,550 2.9

Benefits and claims:

Benefits and claims, net:

Incurred claims -direct 2,183 2,245 2,423 2,892 3,193 765 836 1,581 1,656

Incurred claims -assumed (ceded) 89 104 17 (75) (177) (47) (63) (86) (119)

Increase in FPB -direct 463 326 280 — (55) 15 6 (32) 16

Increase in FPB -assumed (ceded) (11) 4 (5) 4 8 3 3 4 (1)

Total benefits and claims, net, excluding reserve remeasurement 2,724 2,679 2,715 2,821 2,969 736 782 1,467 1,552

Reserve remeasurement (gain) loss (85) (124) (284) (95) (132) (24) (20) (39) (56)

Total benefits and claims, net 2,639 2,555 2,431 2,726 2,837 712 762 7.0 1,428 1,496 4.8

Adjusted expenses:

Amortization of deferred policy acquisition costs 442 455 490 530 551 136 142 4.4 273 285 4.4

Insurance commissions 550 553 561 563 564 139 145 4.3 274 287 4.7

Insurance and other expenses 1,502 1,564 1,640 1,501 1,530 353 352 (0.3) 728 749 2.9

Total adjusted expenses 2,494 2,573 2,691 2,594 2,645 628 639 1,275 1,321

Total benefits and adjusted expenses 5,132 5,127 5,122 5,320 5,482 1,340 1,401 4.6 2,703 2,817 4.2

Pretax adjusted earnings $ 1,356 $ 1,359 $ 1,501 $ 1,419 $ 1,421 $ 388 $ 370 (4.6) % $ 746 $ 733 (1.7) %

Aflac U.S.

Balance Sheets

(In Millions)

December 31, June 30,

2021 2022 2023 2024 2025 2025 2026

Assets:

Investments and cash $ 18,324 $ 15,987 $ 16,718 $ 16,775 $ 17,090 $ 16,864 $ 17,685

Receivables, net of allowance for credit losses (1)

574 584 688 671 707 711 739

Accrued investment income 169 184 183 178 171 180 175

Deferred policy acquisition costs 3,366 3,463 3,573 3,656 3,732 3,682 3,752

Other assets (1)

758 784 698 650 618 601 616

Total assets $ 23,191 $ 21,002 $ 21,861 $ 21,930 $ 22,317 $ 22,038 $ 22,968

Liabilities and Shareholders' Equity:

Future policy benefits $ 14,212 $ 10,870 $ 11,234 $ 10,584 $ 10,798 $ 10,712 $ 10,592

Policy and contract claims 151 200 258 376 483 420 540

Other policy liabilities 119 117 107 103 97 105 99

Deferred income taxes (328) (243) (311) (231) (178) (162) (135)

Other liabilities 2,010 2,080 2,062 2,055 1,621 1,697 1,859

Shareholders' equity 7,027 7,978 8,510 9,043 9,496 9,266 10,012

Total liabilities & shareholders' equity $ 23,191 $ 21,002 $ 21,861 $ 21,930 $ 22,317 $ 22,038 $ 22,968

Aflac U.S.

Quarterly Statements of Pretax Adjusted Earnings and Percentage Changes

(Restated to conform to current classifications)

(In Millions)

Period Net Earned Premiums % Change Adjusted NII % Change Total Adjusted Revenues % Change Benefits & Claims, Net % Change Amort. % Change Total Adjusted Expenses % Change Pretax Adjusted Earn. % Change

2021 $ 5,614 (2.5) % $ 754 7.0 % $ 6,489 (1.2) % $ 2,639 (4.6) % $ 442 (22.5) % $ 2,494 (1.5) % $ 1,356 6.9 %

2022 5,570 (0.8) 755 0.1 6,486 — 2,555 (3.2) 455 2.9 2,573 3.2 1,359 0.2

2023 5,675 1.9 820 8.6 6,623 2.1 2,431 (4.9) 490 7.7 2,691 4.6 1,501 10.4

2024 5,829 2.7 847 3.3 6,739 1.8 2,726 12.1 530 8.2 2,594 (3.6) 1,419 (5.5)

2025 5,999 2.9 830 (2.0) 6,903 2.4 2,837 4.1 551 4.0 2,645 2.0 1,421 0.1

2024 1 1,475 3.3 206 4.6 1,699 2.3 686 5.4 132 10.9 658 0.2 356 1.1

2 1,455 2.1 218 7.4 1,684 1.3 680 5.4 132 10.0 621 (4.2) 383 3.8

3 1,459 2.8 210 0.5 1,684 1.4 694 36.1 132 8.2 640 (5.0) 350 (26.8)

4 1,441 2.7 213 0.9 1,671 2.0 667 6.5 134 3.9 674 (5.3) 330 9.3

2025 1 1,502 1.8 202 (1.9) 1,721 1.3 716 4.4 137 3.8 647 (1.7) 358 0.6

2 1,504 3.4 207 (5.0) 1,728 2.6 712 4.7 136 3.0 628 1.1 388 1.3

3 1,495 2.5 214 1.9 1,728 2.6 681 (1.9) 137 3.8 672 5.0 375 7.1

4 1,498 4.0 207 (2.8) 1,726 3.3 728 9.1 141 5.2 698 3.6 300 (9.1)

2026 1 1,555 3.5 201 (0.5) 1,779 3.4 734 2.5 143 4.4 682 5.4 363 1.4

2 1,539 2.3 208 0.5 1,771 2.5 762 7.0 142 4.4 639 1.8 370 (4.6)

Aflac U.S.

Operating Ratios

(Before Management Fee)

Period

12-Mo. Rolling Premium Persistency

Total Benefit/ Premium Amortization/ Premium Total Adjusted Expenses/ Total Adjusted Revenue Combined Ratio/ Total Adjusted Revenue Pretax Profit Margin

2021 79.7 % 47.0 % 7.9 % 38.4 % 79.1 % 20.9 %

2022 77.3 45.9 8.2 39.7 79.0 21.0

2023 78.6 42.8 8.6 40.6 77.3 22.7

2024 79.3 46.8 9.1 38.5 78.9 21.1

2025 79.2 47.3 9.2 38.3 79.4 20.6

2026 YTD 79.4 48.4 9.2 37.2 79.4 20.6

2024 1 78.7 46.5 8.9 38.7 79.0 21.0

2 78.7 46.7 9.1 36.9 77.3 22.7

3 78.9 47.6 9.0 38.0 79.2 20.8

4 79.3 46.3 9.3 40.3 80.3 19.7

2025 1 79.3 47.7 9.1 37.6 79.2 20.8

2 79.2 47.3 9.0 36.3 77.5 22.5

3 79.0 45.6 9.2 38.9 78.3 21.7

4 79.2 48.6 9.4 40.4 82.6 17.4

2026 1 79.3 47.2 9.2 38.3 79.6 20.4

2 79.4 49.5 9.2 36.1 79.1 20.9

Aflac U.S.

Aflac U.S. Sales Results

(In Millions)

Period Annualized Premiums In Force % Change New Annualized Premiums Sales % Change

2021 $ 6,003 (1.6) % $ 1,278 16.9 %

2022 5,967 (0.6) 1,483 16.1

2023 6,161 3.3 1,558 5.0

2024 6,383 3.6 1,543 (1.0)

2025 6,694 4.9 1,589 3.0

2024 1 6,211 3.1 298 (5.2)

2 6,239 2.9 331 2.0

3 6,265 3.3 379 5.5

4 6,383 3.6 534 (4.5)

2025 1 6,505 4.7 309 3.5

2 6,506 4.3 340 2.7

3 6,500 3.8 390 2.8

4 6,694 4.9 551 3.1

2026 1 6,801 4.6 318 2.9

2 6,799 4.5 349 2.6

Aflac U.S.

Aflac U.S. Product Mix

(New Annualized Premium Sales)

(In Millions)

1 Period Disability % of Total Life % of Total Accident % of Total

Critical Care (1)

% of Total Hospital Indemnity % of Total Dental/ Vision % of Total Total

2021 $ 296 23.1 % $ 114 9.0 % $ 321 25.1 % $ 273 21.3 % $ 209 16.4 % $ 65 5.1 % $ 1,278

2022 378 25.5 156 10.5 338 22.8 299 20.1 226 15.3 85 5.8 1,483

2023 399 25.6 188 12.0 326 20.9 322 20.7 225 14.5 98 6.3 1,558

2024 406 26.3 219 14.2 302 19.6 322 20.9 212 13.7 82 5.3 1,543

2025 420 26.4 246 15.5 300 18.9 315 19.8 209 13.2 98 6.2 1,589

2024 1 69 23.0 32 10.8 67 22.5 66 22.1 45 15.1 19 6.5 298

2 85 25.7 41 12.4 70 21.2 70 21.1 45 13.7 19 5.9 331

3 109 28.8 69 18.3 67 17.7 70 18.6 45 11.9 18 4.7 379

4 143 26.8 77 14.4 97 18.2 115 21.6 76 14.3 25 4.7 534

2025 1 70 22.8 39 12.5 65 21.1 67 21.8 46 15.0 21 6.8 309

2 94 27.7 45 13.1 65 19.0 74 21.8 40 11.9 22 6.5 340

3 130 31.8 76 19.3 66 16.9 55 15.9 41 10.5 22 5.6 390

4 126 22.7 86 15.7 105 19.0 119 21.7 82 14.8 33 6.1 551

2026 1 70 22.0 53 16.7 63 19.8 64 20.3 43 13.5 24 7.7 318

2 92 26.3 66 19.0 64 18.2 60 17.2 41 11.8 26 7.5 349

Aflac U.S. Sales Force Data

Recruited Agents Average Weekly Producer Equivalents Productivity (Production/ Avg. Weekly Producers)

Period Career Broker Total

2021 10,641 5,445 16,086 5,993 213,235

2022 9,550 1,500 11,050 6,186 239,786

2023 10,103 1,463 11,566 6,239 249,663

2024 9,994 1,366 11,360 6,271 256,210

2025 10,048 1,248 11,296 5,341 297,543

2024 1 2,330 346 2,676 5,800 51,432

2 3,113 422 3,535 6,098 54,262

3 2,553 335 2,888 5,890 64,336

4 1,998 263 2,261 6,271 85,225

2025 1 2,405 340 2,745 5,146 59,985

2 3,069 352 3,421 5,354 63,505

3 2,549 302 2,851 5,233 74,459

4 2,025 254 2,279 5,632 97,806

2026 1 2,194 332 2,526 4,982 63,778

2 2,502 349 2,851 5,089 68,574

(1) Includes cancer, critical illness, and hospital intensive care products

Aflac Japan

Statements of Pretax Adjusted Earnings

(Before Management Fee)

(In Millions)

Years Ended December 31, 3 Months Ended June 30, 6 Months Ended June 30,

2021 2022 2023 2024 2025 2025 2026 % Change 2025 2026 % Change

Revenues:

Net earned premiums:

Gross premiums ¥ 1,290,527 ¥ 1,246,657 ¥ 1,212,654 ¥ 1,159,719 ¥ 1,133,651 ¥ 285,931 ¥ 279,844 ¥ 574,250 ¥ 561,716

Assumed (ceded) (50,864) (48,578) (84,838) (109,719) (124,776) (31,357) (34,722) (63,212) (69,933)

Total net earned premiums 1,239,663 1,198,079 1,127,816 1,050,000 1,008,875 254,574 245,122 (3.7) % 511,038 491,783 (3.8) %

Net investment income: (1)

Yen denominated 138,513 149,449 138,073 133,059 133,651 35,622 30,300 (14.9) 69,605 61,145 (12.2)

US$ denominated 202,905 215,171 247,277 280,628 258,933 67,088 69,904 4.2 123,398 134,065 8.6

Net investment income 341,419 364,621 385,352 413,687 392,584 102,709 100,205 (2.4) 193,002 195,210 1.1

Amortized hedge costs on foreign investments (2)

(8,391) (13,155) (19,773) (3,755) (6,754) (1,564) (1,953) 24.9 (2,635) (4,169) 58.2

Adjusted net investment income 333,028 351,466 365,579 409,932 385,830 101,145 98,252 (2.9) 190,367 191,041 0.4

Other income excl. realized foreign currency gains (losses) 4,512 4,442 4,720 4,109 4,739 1,769 1,263 2,565 2,534

Total adjusted revenues 1,577,203 1,553,988 1,498,115 1,464,041 1,399,444 357,488 344,637 (3.6) 703,970 685,357 (2.6)

Benefits and claims:

Benefits and claims, net:

Incurred claims -direct 743,247 788,572 781,774 815,894 854,566 198,189 211,170 437,824 460,814

Incurred claims -assumed (ceded) (31,798) (36,141) (70,748) (82,320) (102,280) (25,321) (24,837) (51,377) (49,887)

Increase in FPB -direct 149,084 73,592 44,121 (26,672) (100,493) (7,471) (30,468) (54,704) (97,338)

Increase in FPB -assumed (ceded) (11,425) (5,618) 2,226 13,877 26,091 6,185 4,680 12,221 9,117

Total benefits and claims, net, excluding reserve remeasurement 849,108 820,405 757,373 720,780 677,884 171,581 160,547 343,964 322,707

Reserve remeasurement (gain) loss (6,879) (13,337) (13,072) (64,197) (79,134) (2,172) (3,782) (5,910) (10,686)

Total benefits and claims, net 842,229 807,068 744,301 656,583 598,750 169,409 156,764 (7.5) 338,054 312,020 (7.7)

Adjusted expenses:

Amortization of deferred policy acquisition costs 43,131 44,123 45,840 48,581 48,397 12,132 12,283 1.2 24,229 24,486 1.1

Insurance commissions 77,449 73,482 68,751 65,889 63,897 16,214 14,962 (7.7) 32,206 29,924 (7.1)

Insurance and other expenses 202,586 198,493 182,364 165,314 174,718 45,423 42,401 (6.7) 85,154 81,584 (4.2)

Total adjusted expenses 323,166 316,097 296,955 279,784 287,012 73,768 69,648 141,589 135,995

Total benefits and adjusted expenses 1,165,395 1,123,165 1,041,256 936,367 885,762 243,178 226,412 (6.9) 479,643 448,015 (6.6)

Pretax adjusted earnings ¥ 411,808 ¥ 430,823 ¥ 456,859 ¥ 527,675 ¥ 513,683 ¥ 114,310 ¥ 118,225 3.4 % ¥ 224,327 ¥ 237,342 5.8 %

(1) Includes the net interest cash flows from derivatives associated with certain investment strategies

(2) See non-U.S. GAAP financial measures for the definition of amortized hedge costs/income

Aflac Japan

Statements of Pretax Adjusted Earnings

(Before Management Fee)

(In Millions)

Years Ended December 31, 3 Months Ended June 30, 6 Months Ended June 30,

2021 2022 2023 2024 2025 2025 2026 % Change 2025 2026 % Change

Revenues:

Net earned premiums

Gross premiums $ 11,765 $ 9,558 $ 8,649 $ 7,654 $ 7,578 $ 1,978 $ 1,755 $ 3,868 $ 3,552

Assumed (ceded) (463) (372) (602) (724) (834) (217) (218) (426) (442)

Total net earned premiums 11,301 9,186 8,047 6,930 6,744 1,761 1,537 (12.7) % 3,442 3,110 (9.6) %

Net investment income (1)

Yen denominated 1,262 1,140 985 879 894 246 190 (22.8) 470 387 (17.7)

US$ denominated 1,845 1,641 1,755 1,849 1,732 464 438 (5.6) 833 847 1.7

Net investment income 3,107 2,782 2,739 2,727 2,626 710 628 (11.5) 1,303 1,234 (5.3)

Amortized hedge costs on foreign investments (2)

(76) (112) (157) (26) (45) (11) (12) 9.1 (18) (27) 50.0

Adjusted net investment income 3,031 2,669 2,582 2,701 2,581 699 616 (11.9) 1,285 1,207 (6.1)

Other income excl. realized foreign currency gains (losses) 41 35 35 28 32 12 8 17 16

Total adjusted revenues 14,373 11,890 10,664 9,659 9,357 2,472 2,161 (12.6) 4,744 4,333 (8.7)

Benefits and claims:

Benefits and claims, net

Incurred claims -direct 6,776 6,038 5,582 5,390 5,707 1,370 1,324 2,942 2,918

Incurred claims -assumed (ceded) (290) (275) (502) (543) (684) (175) (155) (346) (315)

Increase in FPB -direct 1,356 562 314 (184) (671) (53) (191) (363) (619)

Increase in FPB -assumed (ceded) (104) (43) 15 99 175 42 30 82 58

Total benefits and claims, net, excluding reserve remeasurement 7,738 6,282 5,409 4,761 4,528 1,186 1,006 2,316 2,041

Reserve remeasurement (gain) loss (62) (91) (96) (444) (529) (14) (23) (39) (68)

Total benefits and claims, net 7,675 6,191 5,313 4,317 3,999 1,172 983 (16.1) 2,277 1,973 (13.4)

Adjusted expenses:

Amortization of deferred policy acquisition costs 393 338 326 321 323 85 76 (10.6) 164 154 (6.1)

Insurance commissions 706 563 491 435 427 112 94 (16.1) 217 189 (12.9)

Insurance and other expenses 1,843 1,517 1,300 1,092 1,168 313 267 (14.7) 574 517 (9.9)

Total adjusted expenses 2,942 2,417 2,117 1,848 1,918 509 437 954 860

Total benefits and adjusted expenses 10,618 8,609 7,430 6,165 5,917 1,682 1,420 (15.6) 3,232 2,833 (12.3)

Pretax adjusted earnings $ 3,756 $ 3,281 $ 3,234 $ 3,494 $ 3,440 $ 790 $ 741 (6.2) % $ 1,512 $ 1,500 (0.8) %

(1) Includes the net interest cash flows from derivatives associated with certain investment strategies.

(2) See non-U.S. GAAP financial measures for definition of amortized hedge costs/income.

Aflac Japan

Balance Sheets

(In Millions)

December 31, June 30,

2021 2022 2023 2024 2025 2025 2026

Assets:

Investments and cash ¥ 13,645,902 ¥ 12,777,746 ¥ 12,566,939 ¥ 12,216,793 ¥ 11,941,237 ¥ 12,005,337 ¥ 12,210,866

Receivables, net of allowance for credit losses 22,439 23,138 24,848 31,172 26,100 33,409 42,270

Accrued investment income 67,493 76,489 74,666 77,899 82,868 80,758 86,705

Deferred policy acquisition costs 745,510 766,506 788,394 806,920 830,075 812,901 843,733

Other assets 386,832 387,065 946,644 1,136,609 981,002 1,055,055 963,992

Total assets ¥ 14,868,176 ¥ 14,030,944 ¥ 14,401,491 ¥ 14,269,393 ¥ 13,861,283 ¥ 13,987,461 ¥ 14,147,565

Liabilities and Shareholders' Equity:

Future policy benefits ¥ 11,755,704 ¥ 10,315,140 ¥ 10,444,044 ¥ 9,630,864 ¥ 8,234,312 ¥ 8,913,737 ¥ 7,634,308

Policy and contract claims — 28 465 754 1,029 871 1,190

Unearned premiums 284,045 227,732 192,595 189,583 195,068 187,379 203,004

Other policyholders' funds 877,690 880,989 874,854 863,699 852,379 869,166 858,622

Income taxes (prim. deferred) 36,166 114,688 95,297 136,262 236,939 155,422 275,942

Other liabilities 502,633 575,554 576,879 526,477 850,287 1,060,420 1,442,468

Shareholders' equity 1,411,938 1,916,812 2,217,357 2,921,754 3,491,267 2,800,466 3,732,031

Total liabilities & shareholders' equity ¥ 14,868,176 ¥ 14,030,944 ¥ 14,401,491 ¥ 14,269,393 ¥ 13,861,283 ¥ 13,987,461 ¥ 14,147,565

Aflac Japan

Balance Sheets

(In Millions)

December 31, June 30,

2021 2022 2023 2024 2025 2025 2026

Assets:

Investments and cash $ 118,639 $ 96,290 $ 88,606 $ 77,233 $ 76,273 $ 82,904 $ 75,195

Receivables, net of allowance for credit losses 195 174 175 197 167 231 260

Accrued investment income 587 576 526 492 529 558 534

Deferred policy acquisition costs 6,482 5,776 5,559 5,102 5,302 5,614 5,196

Other assets 3,363 2,917 6,675 7,186 6,266 7,286 5,936

Total assets $ 129,266 $ 105,734 $ 101,541 $ 90,210 $ 88,537 $ 96,592 $ 87,121

Liabilities and Shareholders' Equity:

Future policy benefits $ 102,206 $ 77,733 $ 73,638 $ 60,885 $ 52,595 $ 61,555 $ 47,012

Policy and contract claims — — 3 5 7 6 7

Unearned premiums 2,470 1,716 1,358 1,199 1,245 1,294 1,250

Other policyholders' funds 7,631 6,639 6,169 5,460 5,445 6,002 5,288

Income taxes (prim. deferred) 314 781 619 884 1,541 1,046 1,749

Other liabilities 4,369 4,337 4,067 3,328 5,431 7,323 8,883

Shareholders' equity 12,276 14,528 15,687 18,449 22,272 19,366 22,932

Total liabilities & shareholders' equity $ 129,266 $ 105,734 $ 101,541 $ 90,210 $ 88,537 $ 96,592 $ 87,121

Aflac Japan

Quarterly Statements of Pretax Adjusted Earnings and Percentage Changes

(In Millions)

Period Net Earned Premiums % Change Adjusted NII % Change Total Adjusted Revenues % Change Benefits & Claims, Net % Change Amort. % Change Total Adjusted Expense % Change Pretax Adjusted Earn. % Change

2021 ¥ 1,239,663 (8.4) % ¥ 333,028 17.6 % ¥ 1,577,203 (3.9) % ¥ 842,229 (10.9) % ¥ 43,131 (37.3) % ¥ 323,166 (7.0) % ¥ 411,808 18.4 %

2022 1,198,079 (3.4) 351,466 5.5 1,553,988 (1.5) 807,068 (4.2) 44,123 2.3 316,097 (2.2) 430,823 4.6

2023 1,127,816 (5.9) 365,579 4.0 1,498,115 (3.6) 744,301 (7.8) 45,840 3.9 296,955 (6.1) 456,859 6.0

2024 1,050,000 (6.9) 409,932 12.1 1,464,041 (2.3) 656,583 (11.8) 48,581 6.0 279,784 (5.8) 527,675 15.5

2025 1,008,875 (3.9) 385,830 (5.9) 1,399,444 (4.4) 598,750 (8.8) 48,397 (0.4) 287,012 2.6 513,683 (2.7)

2024 1 269,859 (6.0) 96,551 19.3 367,593 (0.4) 180,873 (5.9) 12,289 8.9 66,157 (8.9) 120,564 15.6

2 267,319 (5.7) 112,987 28.4 381,181 2.3 178,904 (4.0) 11,995 5.6 67,754 (6.9) 134,523 18.6

3 255,397 (10.5) 98,969 0.1 355,332 (7.8) 125,548 (32.4) 12,257 7.2 71,039 (2.8) 158,745 25.5

4 257,425 (5.4) 101,425 3.7 359,935 (3.0) 171,258 (4.8) 12,040 2.3 74,834 (4.6) 113,843 1.0

2025 1 256,464 (5.0) 89,222 (7.6) 346,482 (5.7) 168,645 (6.8) 12,097 (1.6) 67,821 2.5 110,017 (8.7)

2 254,574 (4.8) 101,145 (10.5) 357,488 (6.2) 169,409 (5.3) 12,132 1.1 73,768 8.9 114,310 (15.0)

3 245,206 (4.0) 98,032 (0.9) 344,243 (3.1) 96,438 (23.2) 12,028 (1.9) 68,277 (3.9) 179,527 13.1

4 252,631 (1.9) 97,431 (3.9) 351,231 (2.4) 164,258 (4.1) 12,140 0.8 77,146 3.1 109,829 (3.5)

2026 1 246,661 (3.8) 92,789 4.0 340,720 (1.7) 155,256 (7.9) 12,203 0.9 66,347 (2.2) 119,117 8.3

2 245,122 (3.7) 98,252 (2.9) 344,637 (3.6) 156,764 (7.5) 12,283 1.2 69,648 (5.6) 118,225 3.4

Aflac Japan

Operating Ratios

(Before Management Fee)

1 Period

12-Month Rolling Premium Persistency (1)

Total Benefit/ Premium Total Benefit/ Premiums

(3rd sector) Amortization/

Premium Total Adjusted Expenses/

Total Adjusted Revenue Combined Ratio/ Total Adjusted Revenue Pretax Profit Margin

2021 94.3 % 67.9 % 58.7 % 3.5 % 20.5 % 73.9 % 26.1 %

2022 94.1 67.4 58.5 3.7 20.3 72.3 27.7

2023 93.4 66.0 56.2 4.1 19.8 69.5 30.5

2024 93.4 62.5 53.5 4.6 19.1 64.0 36.0

2025 93.1 59.3 49.3 4.8 20.5 63.3 36.7

2026 YTD 92.7 63.4 54.5 5.0 19.8 65.4 34.6

2024 1 93.4 67.0 57.5 4.6 18.0 67.2 32.8

2 93.3 66.9 57.8 4.5 17.8 64.7 35.3

3 93.3 49.2 41.8 4.8 20.0 55.3 44.7

4 93.4 66.5 56.9 4.7 20.8 68.4 31.6

2025 1 93.8 65.8 56.3 4.7 19.6 68.2 31.8

2 93.7 66.5 57.4 4.8 20.6 68.0 32.0

3 93.3 39.3 27.8 4.9 19.8 47.8 52.2

4 93.1 65.0 55.6 4.8 22.0 68.7 31.3

2026 1 92.8 62.9 53.9 4.9 19.5 65.0 35.0

2 92.7 64.0 55.0 5.0 20.2 65.7 34.3

(1) Premium persistency presented on a 12-month rolling basis for all periods. Beginning January 2025, the Company implemented a new methodology of calculating persistency rate which excludes annuitizations, premium halving and waiver premium from the terminations; prior periods have not been retroactively adjusted.

Aflac Japan

Aflac Japan Sales Results

(In Millions, unless otherwise noted)

Period Annualized Premium In Force

(Billions) % Change Third Sector New Annualized Premium Sales % Change Total New Annualized Premium Sales % Change

2021 ¥ 1,360.6 (4.7) % ¥ 48,977 8.6 % ¥ 54,764 7.7 %

2022 1,301.0 (4.4) 47,998 (2.0) 54,765 —

2023 1,246.4 (4.2) 52,234 8.8 60,730 10.9

2024 1,209.0 (3.0) 47,651 (8.8) 64,111 5.6

2025 1,179.1 (2.5) 59,121 24.1 74,351 16.0

2024 1 1,232.6 (3.8) 10,767 (1.7) 12,534 (5.1)

2 1,222.5 (3.6) 12,712 (9.0) 16,833 4.5

3 1,216.7 (3.2) 11,925 (12.4) 17,522 12.3

4 1,209.0 (3.0) 12,246 (10.7) 17,222 9.0

2025 1 1,199.1 (2.7) 10,655 (1.0) 14,112 12.6

2 1,194.1 (2.3) 17,463 37.4 20,736 23.2

3 1,185.7 (2.5) 15,871 33.1 19,586 11.8

4 1,179.1 (2.5) 15,132 23.6 19,918 15.7

2026 1 1,168.9 (2.5) 13,780 29.3 17,712 25.5

2 1,162.1 (2.7) 14,326 (18.0) 19,565 (5.6)

Aflac Japan

Aflac Japan Product Mix

(New Annualized Premium Sales)

(In Billions)

1 Period Cancer % of Total

Medical and Other Health (1)

% of Total Tsumitasu % of Total WAYS % of Total

Ordinary Life Other (2)

% of Total Other % of Total Total

2 2021 ¥ 27.0 49.2 % ¥ 20.7 37.8 % ¥ — — % ¥ 0.4 0.8 % ¥ 5.1 9.3 % ¥ 1.6 2.9 % ¥ 54.8

2022 30.9 56.5 15.3 27.9 — — 1.9 3.5 4.7 8.4 2.0 3.7 54.8

2023 38.9 64.1 12.6 20.8 — — 4.1 6.8 4.1 6.8 1.0 1.6 60.7

2024 36.9 57.5 10.3 16.1 11.2 17.4 1.4 2.2 3.7 5.8 0.6 1.0 64.1

2025 50.0 67.2 8.8 11.9 11.5 15.5 0.8 1.1 2.7 3.7 0.5 0.6 74.4

2024 1 7.9 63.2 2.7 21.5 — — 0.7 5.3 1.0 8.1 0.2 1.7 12.5

2 9.9 58.8 2.7 16.1 2.7 16.2 0.4 2.3 1.0 5.8 0.1 0.6 16.8

3 9.7 55.1 2.2 12.6 4.6 26.5 0.1 0.8 0.8 4.3 0.1 0.6 17.5

4 9.4 54.5 2.8 16.1 3.8 22.1 0.2 1.3 0.9 5.2 0.1 0.8 17.2

2025 1 8.4 59.7 2.2 15.3 2.4 17.2 0.2 1.8 0.7 5.2 0.1 0.8 14.1

2 15.1 73.0 2.3 10.9 2.3 11.1 0.2 1.1 0.7 3.4 0.1 0.5 20.7

3 13.7 70.0 2.1 10.7 2.9 14.6 0.2 1.0 0.6 3.2 0.1 0.5 19.6

4 12.7 63.9 2.3 11.4 3.9 19.8 0.1 0.7 0.7 3.3 0.2 0.9 19.9

2026 1 9.6 54.1 4.2 23.5 2.9 16.1 0.1 0.7 0.8 4.7 0.1 0.9 17.7

2 10.8 55.2 3.5 17.8 4.3 22.0 0.1 0.5 0.7 3.8 0.1 0.7 19.6

(1) Effective March 31, 2026, Income Support is now included with Medical and Other Health for all periods presented

(2) Effective March 31, 2026, Child Endowment is now included with Ordinary Life Other for all periods presented

Aflac Japan

Aflac Japan Sales Force Data

Number of Agencies by Type Sales Contribution by Agency Type

1 Period Individual/ Independent Corporate Affiliated

Corporate Bank Total Individual/ Independent Corporate Affiliated

Corporate Bank

Licensed Sales

Associates (1)

Recruited

Agencies

2021 6,779 1,283 360 8,422 51.1 % 43.7 % 5.2 % 111,854 62

2022 6,159 1,239 359 7,757 49.5 46.5 4.0 110,259 38

2023 5,751 1,203 360 7,314 46.7 50.0 3.3 113,010 24

2024 5,384 1,166 360 6,910 48.2 48.6 3.2 113,836 50

2025 5,155 1,125 358 6,638 47.5 49.2 3.3 111,915 236

2024 1 5,659 1,191 360 7,210 48.9 48.0 3.1 112,645 12

2 5,542 1,180 360 7,082 49.5 48.4 2.1 114,424 12

3 5,464 1,176 360 7,000 46.2 50.2 3.6 114,473 19

4 5,384 1,166 360 6,910 48.5 47.7 3.8 113,836 7

2025 1 5,300 1,155 358 6,813 52.8 43.8 3.4 112,996 18

2 5,225 1,141 358 6,724 46.8 50.4 2.8 111,387 76

3 5,213 1,136 358 6,707 45.1 51.4 3.5 111,736 73

4 5,155 1,125 358 6,638 47.0 49.5 3.5 111,915 69

2026 1 5,110 1,116 357 6,583 52.4 44.6 3.0 111,084 82

2 5,091 1,103 356 6,550 50.0 47.3 2.7 110,750 139

(1) Excludes Dai-ichi Life, banks, Japan Post Group and Daido Life

Aflac Japan

Yen/Dollar Exchange Rates

1 Period

Closing Rate (1)

Quarterly Average Yearly Cumulative Average % Change

2021 115.02 N/A 109.79 (2.7) %

2022 132.70 N/A 130.17 (15.7)

2023 141.83 N/A 140.57 (7.4)

2024 158.18 N/A 150.97 (6.9)

2025 156.56 N/A 149.32 1.1

2024 1 151.41 148.67 148.67 (11.0)

2 161.07 155.70 152.30 (11.4)

3 142.73 147.95 150.60 (8.1)

4 158.18 152.35 150.97 (6.9)

2025 1 149.52 152.40 152.40 (2.4)

2 144.81 144.60 148.32 2.7

3 148.88 147.68 148.03 1.7

4 156.56 154.20 149.32 1.1

2026 1 159.88 156.87 156.87 (2.8)

2 162.39 159.45 158.14 (6.2)

(1) Closing rate is based on the latest available and published MUFG Bank Ltd. TTM mid-day exchange rate.

Corporate and Other

Statements of Pretax Adjusted Earnings

(Before Management Fee)

(In Millions)

Years Ended December 31, 3 Months Ended June 30, 6 Months Ended June 30,

2021 2022 2023 2024 2025 2025 2026 % Change 2025 2026 % Change

Revenues:

Total net earned premiums $ 180 $ 145 $ 400 $ 680 $ 806 $ 206 $ 176 (14.6) % $ 404 $ 358 (11.4) %

Net investment income (1)

(73) 30 (77) 201 368 98 95 (3.1) 194 186 (4.1)

Amortized hedge income (2)

57 68 121 113 98 30 19 (36.7) 60 37 (38.3)

Adjusted net investment income (16) 98 44 314 466 128 114 (10.9) 254 223 (12.2)

Other income 11 24 15 13 5 2 1 (50.0) 4 2 (50.0)

Total adjusted revenues 175 267 460 1,007 1,277 336 291 (13.4) 662 583 (11.9)

Benefits and expenses:

Total benefits and claims, net, excluding reserve remeasurement 161 141 470 426 491 126 108 (14.3) 251 218 (13.1)

Reserve remeasurement (gain) loss — — (3) (19) (33) — (2) — (1) (3) (200.0)

Total benefits and claims, net 161 141 467 407 458 126 106 (15.9) 250 215 (14.0)

Interest expense 165 162 144 156 210 51 62 21.6 96 120 25.0

Other adjusted expenses 142 181 273 412 508 139 133 (4.3) 253 258 2.0

Total benefits and adjusted expenses 469 485 885 975 1,176 316 301 (4.7) 599 593 (1.0)

Pretax adjusted earnings $ (293) $ (218) $ (425) $ 32 $ 101 $ 20 $ (10) (150.0) % $ 63 $ (10) (115.9) %

(2) See non-U.S. GAAP financial measures for the definition of amortized hedge cost/income

Non-U.S. GAAP Financial Measures

The Company defines the non-U.S. GAAP financial measures included in this document as follows:

•

Adjusted book value is the U.S. GAAP book value (representing total shareholders’ equity), less accumulated other comprehensive income as recorded on the U.S. GAAP balance sheet. Adjusted book value per common share is adjusted book value at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value and adjusted book value per common share important as they exclude accumulated other comprehensive income, which fluctuates due to market movements that are outside management’s control. The most comparable U.S. GAAP financial measures for adjusted book value and adjusted book value per common share are total book value and total book value per common share, respectively.

Adjusted book value excluding foreign currency remeasurement is the U.S. GAAP book value (representing total shareholders’ equity), less accumulated other comprehensive income as recorded on the U.S. GAAP balance sheet and excluding the cumulative (beginning January 1, 2021) foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. Adjusted book value excluding foreign currency remeasurement per common share is adjusted book value excluding foreign currency remeasurement at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value excluding foreign currency remeasurement and adjusted book value excluding foreign currency remeasurement per common share important as they exclude both accumulated other comprehensive income and the cumulative foreign currency remeasurement gains/losses, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measures for adjusted book value excluding foreign currency remeasurement and adjusted book value excluding foreign currency remeasurement per common share are total book value and total book value per common share, respectively.

•

Adjusted book value including unrealized foreign currency translation gains and losses and pension liability adjustment is adjusted book value plus unrealized foreign currency translation gains and losses and pension liability adjustment. The Company considers adjusted book value including unrealized foreign currency translation gains and losses and pension liability adjustment important as it excludes certain components of accumulated other comprehensive income, which fluctuates due to market movements that are outside management's control; however, it includes the impact of foreign currency as a result of the significance of Aflac’s Japan operation. The most comparable U.S. GAAP financial measure for adjusted book value including unrealized foreign currency translation gains and losses and pension liability adjustment is total book value.

•

Adjusted debt is the sum of notes payable, as recorded on the U.S. GAAP balance sheet, excluding 50% of subordinated debentures and perpetual bonds and all pre-funding of debt maturities. The Company considers adjusted debt important as it measures outstanding debt consistently with expectations of the Company’s rating agency stakeholders. The most comparable U.S. GAAP financial measure for adjusted debt is notes payable.

•

Adjusted debt including 50% of subordinated debentures and perpetual bonds is the sum of notes payable, as recorded on the U.S. GAAP balance sheet, excluding pre-funding of debt maturities. The Company considers adjusted debt including 50% of subordinated debentures and perpetual bonds important as it measures outstanding debt consistently with expectations of the Company’s rating agency stakeholders. The most comparable U.S. GAAP financial measure for adjusted debt including 50% of subordinated debentures and perpetual bonds is notes payable.

•

Adjusted earnings are adjusted revenues less benefits and adjusted expenses. Adjusted earnings per share (basic or diluted) are the adjusted earnings for the period divided by the weighted average outstanding shares (basic or diluted) for the period presented. The adjustments to both revenues and expenses account for certain items that are outside of management’s control because they tend to be driven by general economic conditions and events or are related to infrequent activities not directly associated with insurance operations. Adjusted revenues are U.S. GAAP total revenues excluding adjusted net investment gains and losses. Adjusted expenses are U.S. GAAP total acquisition and operating expenses including the impact of interest from derivatives associated with notes payable but excluding any non-recurring or other items not associated with the normal course of the Company’s insurance operations and that do not reflect the Company's underlying business performance. Management uses adjusted earnings and adjusted earnings per diluted share to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of these financial measures is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The most comparable U.S. GAAP financial measures for adjusted earnings and adjusted earnings per share (basic or diluted) are net earnings and net earnings per share, respectively.

•

Adjusted earnings excluding current period foreign currency impact are computed using the average foreign exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign exchange rate changes. Adjusted earnings per diluted share excluding current period foreign currency impact is adjusted earnings excluding current period foreign currency impact divided by the weighted average outstanding diluted shares for the period presented. The Company considers adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact important because a significant portion of the Company's business is conducted in Japan and foreign exchange rates are outside management’s control; therefore, the Company believes it is important to understand the impact of translating foreign currency (primarily Japanese yen) into U.S. dollars. The most comparable U.S. GAAP financial measures for adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact are net earnings and net earnings per share, respectively.

•

Amortized hedge costs/income represent costs/income incurred or recognized as a result of using foreign currency derivatives to hedge certain foreign currency exchange risks. These amortized hedge costs/income are estimated at the inception of the derivatives based on the specific terms of each contract and are recognized on a straight-line basis over the contractual term of the derivative. The Company believes that amortized hedge costs/income measure the periodic currency risk management costs/income related to hedging certain foreign currency exchange risks and are an important component of net investment income. There is no comparable U.S. GAAP financial measure for amortized hedge costs/income.

•

Adjusted net investment gains and losses are net investment gains and losses adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, ii) net interest income/expense from foreign currency and interest rate derivatives associated with certain investment strategies, which are both reclassified to net investment income, and iii) the impact of interest from derivatives associated with notes payable, which is reclassified to interest expense as a component of total adjusted expenses. The Company considers adjusted net investment gains and losses important as it represents the remainder amount that is considered outside management’s control, while excluding the components that are within management’s control and are accordingly reclassified to net investment income and interest expense. The most comparable U.S. GAAP financial measure for adjusted net investment gains and losses is net investment gains and losses.

•

Adjusted net investment income is net investment income adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, and ii) net interest income/expense from foreign currency and interest rate derivatives associated with certain investment strategies, which are reclassified from net investment gains and losses to net investment income. The Company considers adjusted net investment income important because it provides a more comprehensive understanding of the costs and income associated with the Company’s investments and related hedging strategies. The most comparable U.S. GAAP financial measure for adjusted net investment income is net investment income.

•

Adjusted return on equity is annualized adjusted earnings divided by average shareholders’ equity, excluding accumulated other comprehensive income. Management uses adjusted return on equity to evaluate the financial performance of the Company’s insurance operations on a consolidated basis and believes that a presentation of this financial measure is vitally important to an understanding of the underlying profitability drivers and trends of the Company’s insurance business. The Company considers adjusted return on equity important as it excludes components of accumulated other comprehensive income, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measure for adjusted return on equity is return on equity as determined using annualized net earnings and average total shareholders’ equity.

•

Adjusted return on equity excluding foreign currency remeasurement is annualized adjusted earnings divided by average shareholders’ equity, excluding both accumulated other comprehensive income and the cumulative (beginning January 1, 2021) foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. The Company considers adjusted return on equity excluding foreign currency remeasurement important because it excludes both accumulated other comprehensive income and the cumulative foreign currency remeasurement gains/losses, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measure for adjusted return on equity excluding foreign currency remeasurement is return on equity as determined using annualized net earnings and average total shareholders’ equity.

Operational Measures

The Company defines the operational measures included in this document as follows:

Operating ratios are used to evaluate the Company's financial condition and profitability. Examples include: (1) Ratios to total adjusted revenues, which present expenses as percentage of total revenues and (2) Ratios to total premium, including benefit ratio. Operating ratios include: Benefit Ratio and Expense Ratio.

New annualized premium sales are sometimes referred to as new sales or sales. An operating measure that is not reflected on the Company's financial statements. New annualized premium sales generally represent annual premiums on policies and riders the Company sold and incremental increases from policy conversions that would be collected over a 12-month period assuming the policies remain in force for that entire period. For Aflac Japan, new annualized premium sales are determined by applications submitted during the reporting period. For Aflac U.S., new annualized premium sales are determined by applications that are issued during the reporting period. Policy conversions are defined as the positive difference in the annualized premium when a policy upgrades in the current reporting period. The Company believes that this metric is a key indicator of the Company's future source of earnings.

Annualized premiums in force is the amount of gross premium that a policyholder must pay over a full year in order to keep coverage. The growth of net earned premiums is directly affected by the change in premiums in force and by the change in weighted-average yen/dollar exchange rates. Management uses this measure as a key indicator of source of earnings.

Premium persistency is the percentage of premiums remaining in force at the end of a period, usually one year, and presented on a trailing 12-month average basis. For example, 95% persistency would mean that 95% of the premiums in force at the beginning of a period are still in force at the end of the period. The Company believes that this metric is a key driver of in force levels, which is a key measure of the size of the Company's business and future sources of earnings.

New money yield is gross yields earned on purchases of fixed maturities, loan receivables, and equities. Purchases exclude capitalized interest, securities lending/repurchase agreements, short-term/cash activity, and alternatives. New money yield for equities is based on the assumed dividend yield at the time of purchase. The new money yield for Aflac Japan excludes the impact of any derivatives and associated amortized hedge costs associated with USD-denominated investments. Management uses this metric as a leading indicator of future investment earning potential.

Return on average invested assets is net investment income as a percentage of average invested assets during the period. Management uses this metric to demonstrate how the Company's actual net investment income results represent an overall return on the portfolio to provide a more comparative metric as the size of the Company's investment portfolio changes over time.

Portfolio book yield expressed as a percentage of the investments' book value, represents the gross return expected to be realized on a security at a point in time and is calculated for fixed maturity securities, commercial mortgage and other loans and equity securities. It excludes amortized hedge costs, investments in limited partnerships and short-term securities. The yield assumes any early redemption options will be exercised. Management uses this metric to measure the future total return on the portfolio.

Average weekly producer is the total number of writing agents, including brokers, in the U.S. who have produced greater than $0.00 during the production week - excluding any manual adjustments - divided by the number of weeks in the time period. The Company believes this metric allows sales management to monitor progress and needs, as well as serve as a leading indicator of future production capacity.

Aflac U.S. productivity is total new annualized sales divided by average weekly producer and is calculated on a quarterly and annual basis. The Company believes this metric allows sales management to monitor agent progress and needs, as well as serve as a leading indicator of future production capacity.

Aflac U.S. recruited agents/brokers represent a newly contracted agent or broker who has never held a contract with the Company before or previously held a contract but has been separated from the Company for more than 365 days. The distinction between a career recruit and a broker recruit is determined by the type of contract the individual signs. The Company believes this metric is an important indicator of future production potential.

EX-99.3

Filename: aflex993teleconferencespee.htm · Sequence: 4

Document

Second Quarter 2026

Earnings Call

Video Update

Max K. Brodén

August 6, 2026

For more information contact:

Investor and Rating Agency Relations

800.235.2667

aflacir@aflac.com

Aflac Worldwide Headquarters

1932 Wynnton Road

Columbus, GA 31999

Forward-Looking Information and Non-U.S. GAAP Financial Measures

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. Aflac Incorporated (the Parent Company) and its subsidiaries (collectively with the Parent Company, the Company) desire to take advantage of these provisions. This transcript contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by company officials in communications with the financial community and contained in documents filed with the Securities and Exchange Commission (SEC). Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks and uncertainties. In particular, statements containing words such as “expect,” “anticipate,” “believe,” “goal,” “objective,” “may,” “should,” “estimate,” “intends,” “projects,” “will,” “assumes,” “potential,” “target,” "outlook" or similar words as well as specific projections of future results, generally qualify as forward-looking. Aflac undertakes no obligation to update such forward-looking statements.

The company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements: